Term,Overlap,P.value,Adjusted.P.value,Old.P.value,Old.Adjusted.P.value,Odds.Ratio,Combined.Score,Genes
neutrophil degranulation (GO:0043312),18/481,8.006842396220088e-18,2.545905671447395e-15,0,0,27.06248071582845,1065.3479809072912,CAP1;SERPINB1;ITGB2;CYBB;SLC2A3;LYZ;MMP8;MPO;SELL;PSAP;S100A12;CTSG;BPI;CEACAM8;B2M;S100A9;S100A8;LTF
neutrophil activation involved in immune response (GO:0002283),18/485,9.268634012158738e-18,2.545905671447395e-15,0,0,26.825175894769043,1052.0805996788604,CAP1;SERPINB1;ITGB2;CYBB;SLC2A3;LYZ;MMP8;MPO;SELL;PSAP;S100A12;CTSG;BPI;CEACAM8;B2M;S100A9;S100A8;LTF
neutrophil mediated immunity (GO:0002446),18/488,1.0335205702763442e-17,2.545905671447395e-15,0,0,26.64984802431611,1042.301555221738,CAP1;SERPINB1;ITGB2;CYBB;SLC2A3;LYZ;MMP8;MPO;SELL;PSAP;S100A12;CTSG;BPI;CEACAM8;B2M;S100A9;S100A8;LTF
defense response to bacterium (GO:0042742),9/176,2.1458299980265892e-10,3.964420921354124e-8,0,0,28.82068295840751,641.6153965316352,S100A12;DEFA3;CTSG;BPI;LYZ;MPO;S100A9;S100A8;LTF
cytokine-mediated signaling pathway (GO:0019221),11/621,1.1756223634532079e-7,1.7375698531838413e-5,0,0,9.966463700234192,159.02786453368324,ITGB2;CFL1;ADAR;CTSG;FOS;GAB2;LCP1;SAMHD1;B2M;MCL1;JAK1
defense response to fungus (GO:0050832),4/24,2.51547457085977e-7,3.098226179775617e-5,0,0,94.92380952380952,1442.4274834555008,S100A12;S100A9;S100A8;LTF
negative regulation of cell development (GO:0010721),4/26,3.527227819376416e-7,3.7237447978845306e-5,0,0,86.28571428571429,1281.9971969903536,RFLNB;B2M;SORL1;LTF
defense response to Gram-negative bacterium (GO:0050829),5/73,6.876222709353073e-7,6.351910727764902e-5,0,0,35.6635581061693,506.06682300540047,DEFA3;CTSG;BPI;LYZ;LTF
retina homeostasis (GO:0001895),4/36,1.3666402521174838e-6,1.1221634959053562e-4,0,0,59.291666666666664,800.6245771157494,LYZ;B2M;ACTB;LTF
positive regulation of inflammatory response (GO:0050729),5/89,1.8489550366126193e-6,1.3663777720567257e-4,0,0,28.8472706155633,380.80964399043,S100A12;MMP8;ETS1;S100A9;S100A8
innate immune response (GO:0045087),7/302,5.3952654143141e-6,3.6246374010710184e-4,0,0,11.961147327249023,145.0885826854332,S100A12;CYBB;DEFA3;ADAR;BPI;B2M;LTF
amyloid fibril formation (GO:1990000),4/63,1.3207526870789883e-5,7.423997478803655e-4,0,0,32.11460855528652,360.7987529980543,LYZ;B2M;SORL1;LTF
inflammatory response (GO:0006954),6/230,1.3817755917583553e-5,7.423997478803655e-4,0,0,13.212053571428571,147.83701505840932,ITGB2;CYBB;FOS;LYZ;S100A9;S100A8
antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),4/64,1.406440659042641e-5,7.423997478803655e-4,0,0,31.57777777777778,352.78261688561037,S100A12;DEFA3;S100A9;LTF
neutrophil chemotaxis (GO:0030593),4/70,2.0092671194441504e-5,9.898989341794848e-4,0,0,28.6984126984127,310.3777938294768,ITGB2;S100A12;S100A9;S100A8
granulocyte chemotaxis (GO:0071621),4/73,2.3731901800629496e-5,0.0010961172144165747,0,0,27.446514837819187,292.2694376238826,ITGB2;S100A12;S100A9;S100A8
neutrophil migration (GO:1990266),4/77,2.9309178077419544e-5,0.0012740872117184142,0,0,25.937377690802347,270.7242287656938,ITGB2;S100A12;S100A9;S100A8
peptidyl-cysteine S-nitrosylation (GO:0018119),2/5,5.152281581570945e-5,0.0021152978271005156,0,0,302.2878787878788,2984.6350856326303,S100A9;S100A8
positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),3/34,6.481302452738128e-5,0.002520885532933409,0,0,44.83795948987247,432.4174597310225,FOS;NR3C1;ETS1
positive regulation of defense response (GO:0031349),4/98,7.552716483275188e-5,0.0027126628638560173,0,0,20.121580547112462,190.97428652767968,S100A12;ETS1;S100A9;S100A8
platelet aggregation (GO:0070527),3/36,7.708514227466355e-5,0.0027126628638560173,0,0,42.116279069767444,398.86643269157304,FLNA;TLN1;ACTB
cellular response to cytokine stimulus (GO:0071345),7/482,1.0725049624588564e-4,0.003450226777030006,0,0,7.360485829959514,67.27736787914965,RIPOR2;ITGB2;CTSG;FOS;GAB2;MCL1;JAK1
regulation of inflammatory response (GO:0050727),5/206,1.0738188886561588e-4,0.003450226777030006,0,0,11.984589248877564,109.52858758301257,S100A12;MMP8;ETS1;S100A9;S100A8
antibacterial humoral response (GO:0019731),3/44,1.411562789923184e-4,0.004082453689479623,0,0,33.88485536018151,300.4110280096531,DEFA3;CTSG;LTF
homotypic cell-cell adhesion (GO:0034109),3/44,1.411562789923184e-4,0.004082453689479623,0,0,33.88485536018151,300.4110280096531,FLNA;TLN1;ACTB
leukocyte aggregation (GO:0070486),2/8,1.4363165889914778e-4,0.004082453689479623,0,0,151.12121212121212,1337.159543603372,S100A9;S100A8
regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),3/45,1.5099573329148714e-4,0.004132809144533667,0,0,33.07641196013289,291.0148384848369,FOS;NR3C1;ETS1
interleukin-12-mediated signaling pathway (GO:0035722),3/46,1.612706528819647e-4,0.0042563933028489966,0,0,32.30557057869118,282.1060216075908,CFL1;LCP1;JAK1
cellular response to interleukin-12 (GO:0071349),3/48,1.8316055930340806e-4,0.004542362417669859,0,0,30.866666666666667,265.6122169240874,CFL1;LCP1;JAK1
peptidyl-cysteine modification (GO:0018198),2/9,1.8439901560229468e-4,0.004542362417669859,0,0,129.52597402597402,1113.7172470762985,S100A9;S100A8
platelet degranulation (GO:0002576),4/125,1.9366664777664856e-4,0.004616762990546558,0,0,15.61038961038961,133.45903076828307,SRGN;PSAP;FLNA;TLN1
positive regulation of intracellular signal transduction (GO:1902533),7/546,2.3111640395156923e-4,0.005207328764923249,0,0,6.465201465201465,54.13047506570163,FLNA;S100A12;GAB2;MMP8;S100A9;S100A8;LTF
regulation of intrinsic apoptotic signaling pathway (GO:2001242),3/52,2.3253294890726277e-4,0.005207328764923249,0,0,28.34124347413384,237.11640779595638,S100A9;S100A8;MCL1
positive regulation of response to external stimulus (GO:0032103),4/139,2.9068855450639804e-4,0.006318201228830239,0,0,13.981657848324515,113.85624885137462,S100A12;ETS1;S100A9;S100A8
actin crosslink formation (GO:0051764),2/12,3.3658272069457453e-4,0.006909295294258072,0,0,90.65454545454546,724.9341768950484,FLNA;LCP1
modulation by host of viral process (GO:0044788),2/12,3.3658272069457453e-4,0.006909295294258072,0,0,90.65454545454546,724.9341768950484,CFL1;LTF
regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),2/13,3.971974518746659e-4,0.007731016833733834,0,0,82.4090909090909,645.3519397906415,ITGB2;ETS1
negative regulation of endopeptidase activity (GO:0010951),3/63,4.1050937015427744e-4,0.007731016833733834,0,0,23.132558139534883,180.3902746645976,SERPINB1;SORL1;LTF
positive regulation of NF-kappaB transcription factor activity (GO:0051092),4/155,4.395712001662764e-4,0.007731016833733834,0,0,12.490066225165563,96.54460043419797,S100A12;S100A9;S100A8;LTF
cellular response to type I interferon (GO:0071357),3/65,4.5008974601774485e-4,0.007731016833733834,0,0,22.384096024006002,172.49326668270768,ADAR;SAMHD1;JAK1
type I interferon signaling pathway (GO:0060337),3/65,4.5008974601774485e-4,0.007731016833733834,0,0,22.384096024006002,172.49326668270768,ADAR;SAMHD1;JAK1
negative regulation of bone mineralization (GO:0030502),2/14,4.6271891745299534e-4,0.007731016833733834,0,0,75.53787878787878,580.0093518719605,SRGN;RFLNB
positive regulation of leukocyte degranulation (GO:0043302),2/14,4.6271891745299534e-4,0.007731016833733834,0,0,75.53787878787878,580.0093518719605,ITGB2;GAB2
extracellular matrix disassembly (GO:0022617),3/66,4.7076557174292633e-4,0.007731016833733834,0,0,22.027685492801773,168.7574095944321,CTSG;LCP1;MMP8
cellular component disassembly (GO:0022411),3/66,4.7076557174292633e-4,0.007731016833733834,0,0,22.027685492801773,168.7574095944321,CTSG;LCP1;MMP8
response to lipopolysaccharide (GO:0032496),4/159,4.8396396071303784e-4,0.007774986238411629,0,0,12.165284178187404,92.86369817754088,DEFA3;CTSG;S100A9;S100A8
protein localization to cell-cell junction (GO:0150105),2/15,5.331252155032125e-4,0.00838254328206115,0,0,69.72377622377623,525.490965769041,ACTB;JAK1
epiboly involved in wound healing (GO:0090505),2/16,6.083945147130895e-4,0.009175582579040267,0,0,64.74025974025975,479.3813605520194,FLNA;LCP1
positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),2/16,6.083945147130895e-4,0.009175582579040267,0,0,64.74025974025975,479.3813605520194,ITGB2;ETS1
cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),4/170,6.224479888990935e-4,0.009199781275928602,0,0,11.352839931153184,83.80496695288002,SELL;ITGB2;EMB;CEACAM8
negative regulation of protein binding (GO:0032091),3/74,6.583755905513038e-4,0.009539991400341442,0,0,19.537831641008843,143.12897674797932,B2M;SORL1;ACTB
regulation of immune response (GO:0050776),4/179,7.550283601632928e-4,0.01073011458001295,0,0,10.764081632653062,77.3803483082343,SELL;ITGB2;SAMHD1;B2M
regulated exocytosis (GO:0045055),4/180,7.708978783243848e-4,0.010748934567579629,0,0,10.702380952380953,76.71418127846742,SRGN;PSAP;FLNA;TLN1
negative regulation of apoptotic process (GO:0043066),6/485,8.113601498548999e-4,0.011103613902643908,0,0,6.098643006263048,43.40281352843155,CFL1;FLNA;CTSG;MPO;MCL1;LTF
negative regulation of nervous system development (GO:0051961),2/19,8.631631629479798e-4,0.011597774134882855,0,0,53.30748663101604,376.07935098604037,SORL1;B2M
regulation of neuron death (GO:1901214),3/86,0.0010195720197132279,0.013454709331572775,0,0,16.702998038666294,115.05646948843464,ITGB2;FOS;SORL1
innate immune response in mucosa (GO:0002227),2/21,0.0010569268597320413,0.013702964023543485,0,0,47.69138755980861,326.7999762595502,DEFA3;LTF
toll-like receptor signaling pathway (GO:0002224),3/91,0.0012006368049580992,0.015297768945931644,0,0,15.75,105.91722527629508,ITGB2;S100A9;S100A8
supramolecular fiber organization (GO:0097435),5/351,0.0012289490717338305,0.015393107864598316,0,0,6.911039052587058,46.31499089691072,KLHL24;LYZ;B2M;SORL1;LTF
"wound healing, spreading of cells (GO:0044319)",2/24,0.0013830203898899714,0.01703420113547815,0,0,41.18181818181818,271.11990217079807,FLNA;LCP1
cell junction assembly (GO:0034329),3/102,0.0016672470711088423,0.020198288287695647,0,0,13.992248062015504,89.5025547215326,FLNA;TLN1;ACTB
negative regulation of programmed cell death (GO:0043069),5/381,0.0017636402334875797,0.02102145375076325,0,0,6.349896211728074,40.260725044227556,CFL1;FLNA;MPO;MCL1;LTF
receptor clustering (GO:0043113),2/28,0.0018830893634099947,0.021743797493124783,0,0,34.83916083916084,218.61021478232786,ITGB2;FLNA
mucosal immune response (GO:0002385),2/28,0.0018830893634099947,0.021743797493124783,0,0,34.83916083916084,218.61021478232786,DEFA3;LTF
regulation of macrophage activation (GO:0043030),2/30,0.002160721100314693,0.024565736817423973,0,0,32.3474025974026,198.5261432195098,BPI;MMP8
positive regulation of leukocyte cell-cell adhesion (GO:1903039),2/31,0.0023063632118604876,0.02582427899340758,0,0,31.230407523510973,189.63363791906963,ITGB2;ETS1
positive regulation of DNA-binding transcription factor activity (GO:0051091),4/246,0.002430524775767497,0.02669668470639141,0,0,7.757575757575758,46.69787607535782,S100A12;S100A9;S100A8;LTF
endodermal cell differentiation (GO:0035987),2/32,0.0024565284980170715,0.02669668470639141,0,0,30.187878787878788,181.39914794415571,ITGB2;MMP8
regulation of protein binding (GO:0043393),3/118,0.0025262384545090047,0.02705637996930659,0,0,12.035793731041457,71.98636947297132,B2M;SORL1;ACTB
actin filament bundle organization (GO:0061572),2/33,0.002611196301997773,0.02756677238823363,0,0,29.212609970674485,173.7550502694207,RFLNB;LCP1
cellular response to lipopolysaccharide (GO:0071222),3/120,0.0026495271610690553,0.027577472845493407,0,0,11.8288610614192,70.18505767322044,DEFA3;CTSG;BPI
regulation of tumor necrosis factor production (GO:0032680),3/124,0.0029071320704851717,0.02970129250411275,0,0,11.43551797040169,66.79015162247424,BPI;MMP8;LTF
negative regulation of neurogenesis (GO:0050768),2/35,0.0029339571756430726,0.02970129250411275,0,0,27.439393939393938,160.01016949426773,B2M;SORL1
endoderm formation (GO:0001706),2/36,0.0031020092699298118,0.030978173655109874,0,0,26.63101604278075,153.81289852825822,ITGB2;MMP8
positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),2/40,0.003818220426103208,0.037622198598536945,0,0,23.822966507177032,132.6455824042491,S100A9;S100A8
skeletal system morphogenesis (GO:0048705),2/42,0.004202444806790308,0.040863246213395224,0,0,22.629545454545454,123.8308828235913,RFLNB;LTF
intracellular steroid hormone receptor signaling pathway (GO:0030518),2/44,0.004603867792024438,0.04418517270527351,0,0,21.549783549783548,115.95633608245093,DEFA3;NR3C1
positive regulation of intracellular protein transport (GO:0090316),3/148,0.004775813613167917,0.04524777256578321,0,0,9.531194867682437,50.936525157945155,ITGB2;FLNA;SORL1
extracellular matrix organization (GO:0030198),4/300,0.004934982181399443,0.046163947241192264,0,0,6.324967824967825,33.594473426353,ITGB2;CTSG;LCP1;MMP8
actin filament organization (GO:0007015),3/152,0.0051434330419726825,0.04751246272522266,0,0,9.273450913063837,48.87140638933629,RFLNB;FLNA;LCP1
positive regulation of neuron death (GO:1901216),2/47,0.00523790183287352,0.04778777104313002,0,0,20.110101010101012,105.61491774669291,ITGB2;FOS
negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),2/48,0.005457674082549767,0.04918562374395461,0,0,19.67193675889328,102.50520162768173,BPI;LTF
positive regulation of reactive oxygen species metabolic process (GO:2000379),2/49,0.005681627397885792,0.05058701984382651,0,0,19.252417794970988,99.5449645426864,ITGB2;MMP8
protein homotetramerization (GO:0051289),2/52,0.0063783787113196565,0.05556978107813284,0,0,18.094545454545454,91.4650562908582,SAMHD1;B2M
cellular response to oxygen-containing compound (GO:1901701),4/323,0.006391652762708108,0.05556978107813284,0,0,5.862068965517241,29.61964163011367,DEFA3;CTSG;FOS;ACTB
regulation of apoptotic process (GO:0042981),6/742,0.006761318541849716,0.0581001674700807,0,0,3.916711956521739,19.56999760884865,CFL1;FLNA;MPO;DUSP6;MCL1;LTF
positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),3/171,0.007120449279876091,0.060482896756648634,0,0,8.216777408637874,40.63019319584977,FLNA;S100A12;LTF
positive regulation of apoptotic signaling pathway (GO:2001235),2/59,0.008146853216535112,0.06841505144340282,0,0,15.86682615629984,76.32139391523698,S100A9;S100A8
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),2/60,0.008415523022552067,0.06934046325498597,0,0,15.592476489028213,74.49582096726616,PSAP;FLNA
negative regulation of cytokine production (GO:0001818),3/182,0.008444711357170146,0.06934046325498597,0,0,7.707548395478758,36.797492457260745,SRGN;BPI;MMP8
pattern recognition receptor signaling pathway (GO:0002221),2/61,0.008688143683921566,0.07055536464195644,0,0,15.327426810477657,72.74084050600412,S100A9;S100A8
regulation of neurogenesis (GO:0050767),2/62,0.00896469642564332,0.0720098984625045,0,0,15.07121212121212,71.05264229068071,B2M;SORL1
positive regulation of cell death (GO:0010942),2/66,0.010109854865250118,0.07230988645525188,0,0,14.126420454545455,64.90023091346157,ITGB2;FOS
cell-cell junction assembly (GO:0007043),2/66,0.010109854865250118,0.07230988645525188,0,0,14.126420454545455,64.90023091346157,TLN1;ACTB
protein localization to membrane (GO:0072657),3/195,0.01018513857643445,0.07230988645525188,0,0,7.180959302325581,32.937808128946614,FYB1;ITGB2;FLNA
regulation of viral genome replication (GO:0045069),2/67,0.010405788552972155,0.07230988645525188,0,0,13.908391608391609,63.49727419150359,ADAR;LTF
interferon-gamma-mediated signaling pathway (GO:0060333),2/68,0.010705542973315047,0.07230988645525188,0,0,13.696969696969697,62.14306435802923,B2M;JAK1
negative regulation of cellular catabolic process (GO:0031330),2/69,0.0110090997812215,0.07230988645525188,0,0,13.491858887381275,60.83523824073091,SORL1;MCL1
defense response to Gram-positive bacterium (GO:0050830),2/70,0.011316440692534107,0.07230988645525188,0,0,13.292780748663102,59.57157940663173,DEFA3;LYZ
protein retention in Golgi apparatus (GO:0045053),1/5,0.011448249952996578,0.07230988645525188,0,0,110.83333333333333,495.41595635428416,SORL1
antifungal humoral response (GO:0019732),1/5,0.011448249952996578,0.07230988645525188,0,0,110.83333333333333,495.41595635428416,LTF
glucose import across plasma membrane (GO:0098708),1/5,0.011448249952996578,0.07230988645525188,0,0,110.83333333333333,495.41595635428416,SLC2A3
regulation of cyclase activity (GO:0031279),1/5,0.011448249952996578,0.07230988645525188,0,0,110.83333333333333,495.41595635428416,CAP1
ribose phosphate metabolic process (GO:0019693),1/5,0.011448249952996578,0.07230988645525188,0,0,110.83333333333333,495.41595635428416,TKT
positive regulation of mast cell activation involved in immune response (GO:0033008),1/5,0.011448249952996578,0.07230988645525188,0,0,110.83333333333333,495.41595635428416,GAB2
positive regulation of neutrophil extravasation (GO:2000391),1/5,0.011448249952996578,0.07230988645525188,0,0,110.83333333333333,495.41595635428416,RIPOR2
cellular response to nicotine (GO:0071316),1/5,0.011448249952996578,0.07230988645525188,0,0,110.83333333333333,495.41595635428416,B2M
positive regulation of oxidative stress-induced neuron death (GO:1903223),1/5,0.011448249952996578,0.07230988645525188,0,0,110.83333333333333,495.41595635428416,MCL1
negative regulation of T cell migration (GO:2000405),1/5,0.011448249952996578,0.07230988645525188,0,0,110.83333333333333,495.41595635428416,RIPOR2
regulation of heart growth (GO:0060420),1/5,0.011448249952996578,0.07230988645525188,0,0,110.83333333333333,495.41595635428416,DUSP6
negative regulation of transcription by RNA polymerase I (GO:0016479),1/5,0.011448249952996578,0.07230988645525188,0,0,110.83333333333333,495.41595635428416,FLNA
regulation of integrin biosynthetic process (GO:0045113),1/5,0.011448249952996578,0.07230988645525188,0,0,110.83333333333333,495.41595635428416,S100A9
chronic inflammatory response (GO:0002544),1/5,0.011448249952996578,0.07230988645525188,0,0,110.83333333333333,495.41595635428416,S100A9
regulation of lyase activity (GO:0051339),1/5,0.011448249952996578,0.07230988645525188,0,0,110.83333333333333,495.41595635428416,CAP1
deoxyribonucleotide metabolic process (GO:0009262),1/5,0.011448249952996578,0.07230988645525188,0,0,110.83333333333333,495.41595635428416,SAMHD1
regulation of neutrophil degranulation (GO:0043313),1/5,0.011448249952996578,0.07230988645525188,0,0,110.83333333333333,495.41595635428416,ITGB2
PML body organization (GO:0030578),1/5,0.011448249952996578,0.07230988645525188,0,0,110.83333333333333,495.41595635428416,ETS1
protein tetramerization (GO:0051262),2/71,0.0116275474889794,0.07281997961318455,0,0,13.099472990777338,58.350007087698046,SAMHD1;B2M
cell junction organization (GO:0034330),2/72,0.011942402007789574,0.07380827348724454,0,0,12.911688311688312,57.168566103425825,FLNA;ACTB
"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",2/73,0.012260986149212767,0.07380827348724454,0,0,12.729193341869399,56.02541764199213,CYBB;B2M
response to molecule of bacterial origin (GO:0002237),2/73,0.012260986149212767,0.07380827348724454,0,0,12.729193341869399,56.02541764199213,S100A9;S100A8
integrin-mediated signaling pathway (GO:0007229),2/75,0.012909271198759906,0.07380827348724454,0,0,12.37920298879203,53.84717511186808,FYB1;ITGB2
positive regulation of growth (GO:0045927),2/76,0.013238936206266351,0.07380827348724454,0,0,12.211302211302211,52.80891302442309,S100A9;S100A8
purine deoxyribonucleotide catabolic process (GO:0009155),1/6,0.013722475176735492,0.07380827348724454,0,0,88.66222222222223,380.24746931631483,SAMHD1
regulation of adipose tissue development (GO:1904177),1/6,0.013722475176735492,0.07380827348724454,0,0,88.66222222222223,380.24746931631483,SORL1
astrocyte development (GO:0014002),1/6,0.013722475176735492,0.07380827348724454,0,0,88.66222222222223,380.24746931631483,S100A9
glycolipid transport (GO:0046836),1/6,0.013722475176735492,0.07380827348724454,0,0,88.66222222222223,380.24746931631483,PSAP
hexose import across plasma membrane (GO:0140271),1/6,0.013722475176735492,0.07380827348724454,0,0,88.66222222222223,380.24746931631483,SLC2A3
positive regulation of microglial cell activation (GO:1903980),1/6,0.013722475176735492,0.07380827348724454,0,0,88.66222222222223,380.24746931631483,MMP8
cellular response to iron ion (GO:0071281),1/6,0.013722475176735492,0.07380827348724454,0,0,88.66222222222223,380.24746931631483,B2M
positive regulation of osteoblast proliferation (GO:0033690),1/6,0.013722475176735492,0.07380827348724454,0,0,88.66222222222223,380.24746931631483,LTF
negative regulation of triglyceride metabolic process (GO:0090209),1/6,0.013722475176735492,0.07380827348724454,0,0,88.66222222222223,380.24746931631483,SORL1
positive regulation of receptor binding (GO:1900122),1/6,0.013722475176735492,0.07380827348724454,0,0,88.66222222222223,380.24746931631483,B2M
regulation of macromolecule biosynthetic process (GO:0010556),1/6,0.013722475176735492,0.07380827348724454,0,0,88.66222222222223,380.24746931631483,S100A9
type B pancreatic cell proliferation (GO:0044342),1/6,0.013722475176735492,0.07380827348724454,0,0,88.66222222222223,380.24746931631483,SERPINB1
"pentose-phosphate shunt, non-oxidative branch (GO:0009052)",1/6,0.013722475176735492,0.07380827348724454,0,0,88.66222222222223,380.24746931631483,TKT
regulation of neutrophil extravasation (GO:2000389),1/6,0.013722475176735492,0.07380827348724454,0,0,88.66222222222223,380.24746931631483,RIPOR2
antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),2/78,0.013909221884793927,0.07380827348724454,0,0,11.888755980861244,50.82684777839637,CYBB;B2M
cellular response to lipid (GO:0071396),3/219,0.013911148991634814,0.07380827348724454,0,0,6.375322997416021,27.25491813551528,DEFA3;CTSG;NR3C1
positive regulation of cellular process (GO:0048522),5/625,0.013982622852793284,0.07380827348724454,0,0,3.802911093627065,16.238201986436753,NAMPT;GAB2;ETS1;S100A9;S100A8
regulation of organelle organization (GO:0033043),2/80,0.014593996737903651,0.07432565914262214,0,0,11.582750582750583,48.961966410902626,S100A9;S100A8
regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),3/224,0.014772716120379632,0.07432565914262214,0,0,6.229506471640534,26.257203480910515,FLNA;S100A12;LTF
activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),2/81,0.014941773437818155,0.07432565914262214,0,0,11.435558112773302,48.070448070239884,S100A9;S100A8
aldehyde biosynthetic process (GO:0046184),1/7,0.015991582954907876,0.07432565914262214,0,0,73.88148148148149,305.55110809661255,TKT
astrocyte differentiation (GO:0048708),1/7,0.015991582954907876,0.07432565914262214,0,0,73.88148148148149,305.55110809661255,S100A9
regulation of atrial cardiac muscle cell membrane repolarization (GO:0060372),1/7,0.015991582954907876,0.07432565914262214,0,0,73.88148148148149,305.55110809661255,FLNA
glyceraldehyde-3-phosphate metabolic process (GO:0019682),1/7,0.015991582954907876,0.07432565914262214,0,0,73.88148148148149,305.55110809661255,TKT
response to host defenses (GO:0052200),1/7,0.015991582954907876,0.07432565914262214,0,0,73.88148148148149,305.55110809661255,B2M
positive regulation of integrin-mediated signaling pathway (GO:2001046),1/7,0.015991582954907876,0.07432565914262214,0,0,73.88148148148149,305.55110809661255,FLNA
ribose phosphate biosynthetic process (GO:0046390),1/7,0.015991582954907876,0.07432565914262214,0,0,73.88148148148149,305.55110809661255,TKT
regulation of dopamine metabolic process (GO:0042053),1/7,0.015991582954907876,0.07432565914262214,0,0,73.88148148148149,305.55110809661255,ITGB2
negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),1/7,0.015991582954907876,0.07432565914262214,0,0,73.88148148148149,305.55110809661255,ADAR
iron coordination entity transport (GO:1901678),1/7,0.015991582954907876,0.07432565914262214,0,0,73.88148148148149,305.55110809661255,LTF
iron import into cell (GO:0033212),1/7,0.015991582954907876,0.07432565914262214,0,0,73.88148148148149,305.55110809661255,LTF
positive regulation of podosome assembly (GO:0071803),1/7,0.015991582954907876,0.07432565914262214,0,0,73.88148148148149,305.55110809661255,LCP1
miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),1/7,0.015991582954907876,0.07432565914262214,0,0,73.88148148148149,305.55110809661255,ADAR
modulation by symbiont of host apoptotic process (GO:0052150),1/7,0.015991582954907876,0.07432565914262214,0,0,73.88148148148149,305.55110809661255,CTSG
modulation by symbiont of host defense response (GO:0052031),1/7,0.015991582954907876,0.07432565914262214,0,0,73.88148148148149,305.55110809661255,B2M
regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),1/7,0.015991582954907876,0.07432565914262214,0,0,73.88148148148149,305.55110809661255,MCL1
negative regulation of binding (GO:0051100),2/88,0.01747517756376507,0.0757914428296503,0,0,10.501057082452432,42.49750319894254,SORL1;ACTB
axonogenesis (GO:0007409),3/240,0.01773029549783489,0.0757914428296503,0,0,5.804239034442155,23.405480680139043,EMB;GAB2;ACTB
positive regulation of binding (GO:0051099),2/90,0.018230298727214638,0.0757914428296503,0,0,10.261363636363637,41.09337823158696,MMP8;B2M
negative regulation of protein kinase activity (GO:0006469),2/90,0.018230298727214638,0.0757914428296503,0,0,10.261363636363637,41.09337823158696,ADAR;SORL1
adenosine to inosine editing (GO:0006382),1/8,0.018255584335152574,0.0757914428296503,0,0,63.32380952380952,253.50320962011816,ADAR
antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),1/8,0.018255584335152574,0.0757914428296503,0,0,63.32380952380952,253.50320962011816,B2M
"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",1/8,0.018255584335152574,0.0757914428296503,0,0,63.32380952380952,253.50320962011816,B2M
positive regulation of endocytic recycling (GO:2001137),1/8,0.018255584335152574,0.0757914428296503,0,0,63.32380952380952,253.50320962011816,SORL1
positive regulation of homotypic cell-cell adhesion (GO:0034112),1/8,0.018255584335152574,0.0757914428296503,0,0,63.32380952380952,253.50320962011816,JAK1
positive regulation of isomerase activity (GO:0010912),1/8,0.018255584335152574,0.0757914428296503,0,0,63.32380952380952,253.50320962011816,ITGB2
interleukin-21-mediated signaling pathway (GO:0038114),1/8,0.018255584335152574,0.0757914428296503,0,0,63.32380952380952,253.50320962011816,JAK1
cellular response to interleukin-21 (GO:0098757),1/8,0.018255584335152574,0.0757914428296503,0,0,63.32380952380952,253.50320962011816,JAK1
somatic hypermutation of immunoglobulin genes (GO:0016446),1/8,0.018255584335152574,0.0757914428296503,0,0,63.32380952380952,253.50320962011816,SAMHD1
positive regulation of protein localization to early endosome (GO:1902966),1/8,0.018255584335152574,0.0757914428296503,0,0,63.32380952380952,253.50320962011816,SORL1
positive regulation of protein localization to endosome (GO:1905668),1/8,0.018255584335152574,0.0757914428296503,0,0,63.32380952380952,253.50320962011816,SORL1
regulation of osteoclast development (GO:2001204),1/8,0.018255584335152574,0.0757914428296503,0,0,63.32380952380952,253.50320962011816,LTF
negative regulation by symbiont of host apoptotic process (GO:0033668),1/8,0.018255584335152574,0.0757914428296503,0,0,63.32380952380952,253.50320962011816,CTSG
negative regulation by symbiont of host programmed cell death (GO:0052041),1/8,0.018255584335152574,0.0757914428296503,0,0,63.32380952380952,253.50320962011816,CTSG
regulation of protein localization to early endosome (GO:1902965),1/8,0.018255584335152574,0.0757914428296503,0,0,63.32380952380952,253.50320962011816,SORL1
negative regulation of MAPK cascade (GO:0043409),2/94,0.019781373014179343,0.08063940644340241,0,0,9.813241106719367,38.497487555319324,SORL1;DUSP6
regulation of transmembrane transporter activity (GO:0022898),1/9,0.020514490407793847,0.08063940644340241,0,0,55.40555555555556,215.34055050751047,ACTB
regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),1/9,0.020514490407793847,0.08063940644340241,0,0,55.40555555555556,215.34055050751047,SORL1
regulation of tumor necrosis factor superfamily cytokine production (GO:1903555),1/9,0.020514490407793847,0.08063940644340241,0,0,55.40555555555556,215.34055050751047,LTF
positive regulation of mast cell degranulation (GO:0043306),1/9,0.020514490407793847,0.08063940644340241,0,0,55.40555555555556,215.34055050751047,GAB2
interleukin-9-mediated signaling pathway (GO:0038113),1/9,0.020514490407793847,0.08063940644340241,0,0,55.40555555555556,215.34055050751047,JAK1
regulation of ER to Golgi vesicle-mediated transport (GO:0060628),1/9,0.020514490407793847,0.08063940644340241,0,0,55.40555555555556,215.34055050751047,SORL1
cellular response to interleukin-9 (GO:0071355),1/9,0.020514490407793847,0.08063940644340241,0,0,55.40555555555556,215.34055050751047,JAK1
small RNA loading onto RISC (GO:0070922),1/9,0.020514490407793847,0.08063940644340241,0,0,55.40555555555556,215.34055050751047,ADAR
L-ascorbic acid metabolic process (GO:0019852),1/9,0.020514490407793847,0.08063940644340241,0,0,55.40555555555556,215.34055050751047,SLC2A3
protein maturation (GO:0051604),2/97,0.020979874821726353,0.08160067101713565,0,0,9.501913875598087,36.71721618664278,SRGN;SORL1
regulation of MAP kinase activity (GO:0043405),2/97,0.020979874821726353,0.08160067101713565,0,0,9.501913875598087,36.71721618664278,S100A12;SORL1
cellular component assembly (GO:0022607),3/261,0.022079838057521003,0.08167855711290632,0,0,5.326122228231476,20.308985494828985,FLNA;LCP1;ACTB
regulation of receptor binding (GO:1900120),1/10,0.022768312266926525,0.08167855711290632,0,0,49.24691358024691,186.27081295676348,B2M
adherens junction assembly (GO:0034333),1/10,0.022768312266926525,0.08167855711290632,0,0,49.24691358024691,186.27081295676348,ACTB
receptor recycling (GO:0001881),1/10,0.022768312266926525,0.08167855711290632,0,0,49.24691358024691,186.27081295676348,SORL1
regulation of tau-protein kinase activity (GO:1902947),1/10,0.022768312266926525,0.08167855711290632,0,0,49.24691358024691,186.27081295676348,SORL1
apical protein localization (GO:0045176),1/10,0.022768312266926525,0.08167855711290632,0,0,49.24691358024691,186.27081295676348,ACTB
negative regulation of inclusion body assembly (GO:0090084),1/10,0.022768312266926525,0.08167855711290632,0,0,49.24691358024691,186.27081295676348,SORL1
granulocyte migration (GO:0097530),1/10,0.022768312266926525,0.08167855711290632,0,0,49.24691358024691,186.27081295676348,ITGB2
negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665),1/10,0.022768312266926525,0.08167855711290632,0,0,49.24691358024691,186.27081295676348,LTF
secretory granule organization (GO:0033363),1/10,0.022768312266926525,0.08167855711290632,0,0,49.24691358024691,186.27081295676348,SRGN
negative regulation of receptor binding (GO:1900121),1/10,0.022768312266926525,0.08167855711290632,0,0,49.24691358024691,186.27081295676348,B2M
positive regulation of myoblast fusion (GO:1901741),1/10,0.022768312266926525,0.08167855711290632,0,0,49.24691358024691,186.27081295676348,RIPOR2
positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),1/10,0.022768312266926525,0.08167855711290632,0,0,49.24691358024691,186.27081295676348,LTF
modulation by symbiont of host process (GO:0044003),1/10,0.022768312266926525,0.08167855711290632,0,0,49.24691358024691,186.27081295676348,B2M
regulation of organ growth (GO:0046620),1/10,0.022768312266926525,0.08167855711290632,0,0,49.24691358024691,186.27081295676348,DUSP6
regulation of podosome assembly (GO:0071801),1/10,0.022768312266926525,0.08167855711290632,0,0,49.24691358024691,186.27081295676348,LCP1
positive regulation of cell growth (GO:0030307),2/102,0.02304308305144431,0.08186941526450646,0,0,9.024545454545455,34.026052679494455,S100A9;S100A8
regulation of protein catabolic process (GO:0042176),2/102,0.02304308305144431,0.08186941526450646,0,0,9.024545454545455,34.026052679494455,FLNA;SORL1
positive regulation of protein serine/threonine kinase activity (GO:0071902),2/106,0.02475159898664617,0.08403458225197374,0,0,8.6756993006993,32.090242112187305,S100A12;LTF
actin filament depolymerization (GO:0030042),1/11,0.025017061022238465,0.08403458225197374,0,0,44.32,163.46090194189088,CFL1
actin filament network formation (GO:0051639),1/11,0.025017061022238465,0.08403458225197374,0,0,44.32,163.46090194189088,LCP1
positive regulation of cellular extravasation (GO:0002693),1/11,0.025017061022238465,0.08403458225197374,0,0,44.32,163.46090194189088,RIPOR2
positive regulation of cytoplasmic transport (GO:1903651),1/11,0.025017061022238465,0.08403458225197374,0,0,44.32,163.46090194189088,SORL1
negative regulation of lymphocyte migration (GO:2000402),1/11,0.025017061022238465,0.08403458225197374,0,0,44.32,163.46090194189088,RIPOR2
regulation of endocytic recycling (GO:2001135),1/11,0.025017061022238465,0.08403458225197374,0,0,44.32,163.46090194189088,SORL1
interleukin-2-mediated signaling pathway (GO:0038110),1/11,0.025017061022238465,0.08403458225197374,0,0,44.32,163.46090194189088,JAK1
interleukin-35-mediated signaling pathway (GO:0070757),1/11,0.025017061022238465,0.08403458225197374,0,0,44.32,163.46090194189088,JAK1
cellular response to interleukin-2 (GO:0071352),1/11,0.025017061022238465,0.08403458225197374,0,0,44.32,163.46090194189088,JAK1
positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),1/11,0.025017061022238465,0.08403458225197374,0,0,44.32,163.46090194189088,NAMPT
positive regulation by host of viral process (GO:0044794),1/11,0.025017061022238465,0.08403458225197374,0,0,44.32,163.46090194189088,CFL1
regulation of interleukin-6 production (GO:0032675),2/110,0.026510499355673414,0.0858258410226007,0,0,8.352693602693602,30.322068782022388,BPI;MMP8
Fc-epsilon receptor signaling pathway (GO:0038095),2/111,0.026957976643237177,0.0858258410226007,0,0,8.275646371976647,29.90384993096215,FOS;GAB2
regulation of protein serine/threonine kinase activity (GO:0071900),2/111,0.026957976643237177,0.0858258410226007,0,0,8.275646371976647,29.90384993096215,ACTB;LTF
adipose tissue development (GO:0060612),1/12,0.02726074776388067,0.0858258410226007,0,0,40.28888888888889,145.1329634798573,NAMPT
angiotensin maturation (GO:0002003),1/12,0.02726074776388067,0.0858258410226007,0,0,40.28888888888889,145.1329634798573,CTSG
positive regulation of cellular senescence (GO:2000774),1/12,0.02726074776388067,0.0858258410226007,0,0,40.28888888888889,145.1329634798573,B2M
regulation of angiotensin levels in blood (GO:0002002),1/12,0.02726074776388067,0.0858258410226007,0,0,40.28888888888889,145.1329634798573,CTSG
regulation of triglyceride catabolic process (GO:0010896),1/12,0.02726074776388067,0.0858258410226007,0,0,40.28888888888889,145.1329634798573,SORL1
positive regulation of myeloid leukocyte mediated immunity (GO:0002888),1/12,0.02726074776388067,0.0858258410226007,0,0,40.28888888888889,145.1329634798573,ITGB2
positive regulation of neuroinflammatory response (GO:0150078),1/12,0.02726074776388067,0.0858258410226007,0,0,40.28888888888889,145.1329634798573,MMP8
nuclear body organization (GO:0030575),1/12,0.02726074776388067,0.0858258410226007,0,0,40.28888888888889,145.1329634798573,ETS1
regulation of myoblast fusion (GO:1901739),1/12,0.02726074776388067,0.0858258410226007,0,0,40.28888888888889,145.1329634798573,RIPOR2
morphogenesis of a polarized epithelium (GO:0001738),1/12,0.02726074776388067,0.0858258410226007,0,0,40.28888888888889,145.1329634798573,ACTB
negative regulation by host of viral process (GO:0044793),1/12,0.02726074776388067,0.0858258410226007,0,0,40.28888888888889,145.1329634798573,LTF
Fc receptor signaling pathway (GO:0038093),2/112,0.027408522978800767,0.0858258410226007,0,0,8.2,29.49459030195551,FOS;GAB2
regulation of cytoskeleton organization (GO:0051493),2/112,0.027408522978800767,0.0858258410226007,0,0,8.2,29.49459030195551,S100A9;S100A8
proteolysis (GO:0006508),3/287,0.028204799945901183,0.08616618366306754,0,0,4.832132328856862,17.24231950596593,SRGN;CTSG;MMP8
response to lipid (GO:0033993),2/114,0.028318759568829368,0.08616618366306754,0,0,8.05275974025974,28.701894385061102,S100A9;S100A8
cellular response to transforming growth factor beta stimulus (GO:0071560),2/114,0.028318759568829368,0.08616618366306754,0,0,8.05275974025974,28.701894385061102,FOS;NR3C1
cellular response to molecule of bacterial origin (GO:0071219),2/115,0.02877841834664588,0.08616618366306754,0,0,7.9810941271118265,28.31795579974051,DEFA3;CTSG
positive regulation of angiogenesis (GO:0045766),2/116,0.029241083213792377,0.08616618366306754,0,0,7.910685805422648,27.94197092805443,ETS1;JAK1
positive regulation of cell aging (GO:0090343),1/13,0.029499383581537333,0.08616618366306754,0,0,36.92962962962963,130.1173367501014,B2M
glucose import (GO:0046323),1/13,0.029499383581537333,0.08616618366306754,0,0,36.92962962962963,130.1173367501014,SLC2A3
response to iron ion (GO:0010039),1/13,0.029499383581537333,0.08616618366306754,0,0,36.92962962962963,130.1173367501014,B2M
positive regulation of insulin receptor signaling pathway (GO:0046628),1/13,0.029499383581537333,0.08616618366306754,0,0,36.92962962962963,130.1173367501014,SORL1
interleukin-15-mediated signaling pathway (GO:0035723),1/13,0.029499383581537333,0.08616618366306754,0,0,36.92962962962963,130.1173367501014,JAK1
cellular response to interleukin-15 (GO:0071350),1/13,0.029499383581537333,0.08616618366306754,0,0,36.92962962962963,130.1173367501014,JAK1
regulation of homotypic cell-cell adhesion (GO:0034110),1/13,0.029499383581537333,0.08616618366306754,0,0,36.92962962962963,130.1173367501014,JAK1
positive regulation of protein exit from endoplasmic reticulum (GO:0070863),1/13,0.029499383581537333,0.08616618366306754,0,0,36.92962962962963,130.1173367501014,SORL1
positive regulation of reactive oxygen species biosynthetic process (GO:1903428),1/13,0.029499383581537333,0.08616618366306754,0,0,36.92962962962963,130.1173367501014,MMP8
cytoplasmic sequestering of protein (GO:0051220),1/13,0.029499383581537333,0.08616618366306754,0,0,36.92962962962963,130.1173367501014,FLNA
pentose-phosphate shunt (GO:0006098),1/13,0.029499383581537333,0.08616618366306754,0,0,36.92962962962963,130.1173367501014,TKT
regulation of protein exit from endoplasmic reticulum (GO:0070861),1/13,0.029499383581537333,0.08616618366306754,0,0,36.92962962962963,130.1173367501014,SORL1
positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),2/119,0.03064695858007763,0.08717721890923895,0,0,7.706682206682206,26.85949723461201,S100A9;S100A8
cellular response to interferon-gamma (GO:0071346),2/121,0.03159895459071964,0.08717721890923895,0,0,7.576394194041253,26.173648080719847,B2M;JAK1
protein homooligomerization (GO:0051260),2/121,0.03159895459071964,0.08717721890923895,0,0,7.576394194041253,26.173648080719847,SAMHD1;B2M
regulation of response to interferon-gamma (GO:0060330),1/14,0.03173297954882987,0.08717721890923895,0,0,34.08717948717949,117.61436233167083,JAK1
positive regulation of cellular response to insulin stimulus (GO:1900078),1/14,0.03173297954882987,0.08717721890923895,0,0,34.08717948717949,117.61436233167083,SORL1
antigen processing and presentation of endogenous peptide antigen (GO:0002483),1/14,0.03173297954882987,0.08717721890923895,0,0,34.08717948717949,117.61436233167083,B2M
bone morphogenesis (GO:0060349),1/14,0.03173297954882987,0.08717721890923895,0,0,34.08717948717949,117.61436233167083,LTF
response to chemokine (GO:1990868),1/14,0.03173297954882987,0.08717721890923895,0,0,34.08717948717949,117.61436233167083,RIPOR2
cellular response to low-density lipoprotein particle stimulus (GO:0071404),1/14,0.03173297954882987,0.08717721890923895,0,0,34.08717948717949,117.61436233167083,ITGB2
low-density lipoprotein particle remodeling (GO:0034374),1/14,0.03173297954882987,0.08717721890923895,0,0,34.08717948717949,117.61436233167083,MPO
ceramide transport (GO:0035627),1/14,0.03173297954882987,0.08717721890923895,0,0,34.08717948717949,117.61436233167083,PSAP
regulation of integrin-mediated signaling pathway (GO:2001044),1/14,0.03173297954882987,0.08717721890923895,0,0,34.08717948717949,117.61436233167083,FLNA
positive regulation of superoxide anion generation (GO:0032930),1/14,0.03173297954882987,0.08717721890923895,0,0,34.08717948717949,117.61436233167083,ITGB2
regulation of nitric-oxide synthase biosynthetic process (GO:0051769),1/14,0.03173297954882987,0.08717721890923895,0,0,34.08717948717949,117.61436233167083,NAMPT
pre-miRNA processing (GO:0031054),1/14,0.03173297954882987,0.08717721890923895,0,0,34.08717948717949,117.61436233167083,ADAR
NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),1/14,0.03173297954882987,0.08717721890923895,0,0,34.08717948717949,117.61436233167083,NAMPT
regulation of anatomical structure morphogenesis (GO:0022603),2/123,0.03256260365451254,0.08868403897498912,0,0,7.450413223140496,25.514616403036424,CFL1;ETS1
defense response to symbiont (GO:0140546),2/124,0.03304875989608712,0.08868403897498912,0,0,7.388971684053652,25.194703107790918,FLNA;SAMHD1
cellular response to oxidative stress (GO:0034599),2/125,0.033537783672173915,0.08868403897498912,0,0,7.3285291943828526,24.88096198741252,CYBB;FOS
establishment of spindle localization (GO:0051293),1/15,0.03396154672519881,0.08868403897498912,0,0,31.650793650793652,107.05964425258333,CFL1
regulation of superoxide anion generation (GO:0032928),1/15,0.03396154672519881,0.08868403897498912,0,0,31.650793650793652,107.05964425258333,ITGB2
negative regulation of chondrocyte differentiation (GO:0032331),1/15,0.03396154672519881,0.08868403897498912,0,0,31.650793650793652,107.05964425258333,RFLNB
negative regulation of leukocyte activation (GO:0002695),1/15,0.03396154672519881,0.08868403897498912,0,0,31.650793650793652,107.05964425258333,BPI
interleukin-27-mediated signaling pathway (GO:0070106),1/15,0.03396154672519881,0.08868403897498912,0,0,31.650793650793652,107.05964425258333,JAK1
steroid hormone mediated signaling pathway (GO:0043401),1/15,0.03396154672519881,0.08868403897498912,0,0,31.650793650793652,107.05964425258333,NR3C1
superoxide anion generation (GO:0042554),1/15,0.03396154672519881,0.08868403897498912,0,0,31.650793650793652,107.05964425258333,CYBB
positive regulation of sprouting angiogenesis (GO:1903672),1/15,0.03396154672519881,0.08868403897498912,0,0,31.650793650793652,107.05964425258333,JAK1
regulation of microglial cell activation (GO:1903978),1/15,0.03396154672519881,0.08868403897498912,0,0,31.650793650793652,107.05964425258333,MMP8
mRNA methylation (GO:0080009),1/15,0.03396154672519881,0.08868403897498912,0,0,31.650793650793652,107.05964425258333,WTAP
protein kinase A signaling (GO:0010737),1/15,0.03396154672519881,0.08868403897498912,0,0,31.650793650793652,107.05964425258333,LCP1
negative regulation of anoikis (GO:2000811),1/16,0.036185096144207514,0.09157803441975806,0,0,29.53925925925926,98.04399035231516,MCL1
negative regulation of macrophage activation (GO:0043031),1/16,0.036185096144207514,0.09157803441975806,0,0,29.53925925925926,98.04399035231516,BPI
regulation of establishment of cell polarity (GO:2000114),1/16,0.036185096144207514,0.09157803441975806,0,0,29.53925925925926,98.04399035231516,RIPOR2
cellular response to corticosteroid stimulus (GO:0071384),1/16,0.036185096144207514,0.09157803441975806,0,0,29.53925925925926,98.04399035231516,NR3C1
negative regulation of type I interferon-mediated signaling pathway (GO:0060339),1/16,0.036185096144207514,0.09157803441975806,0,0,29.53925925925926,98.04399035231516,SAMHD1
regulation of mast cell degranulation (GO:0043304),1/16,0.036185096144207514,0.09157803441975806,0,0,29.53925925925926,98.04399035231516,GAB2
positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),1/16,0.036185096144207514,0.09157803441975806,0,0,29.53925925925926,98.04399035231516,RIPOR2
nucleotide catabolic process (GO:0009166),1/16,0.036185096144207514,0.09157803441975806,0,0,29.53925925925926,98.04399035231516,SAMHD1
dendrite self-avoidance (GO:0070593),1/16,0.036185096144207514,0.09157803441975806,0,0,29.53925925925926,98.04399035231516,EMB
cellular response to metal ion (GO:0071248),2/131,0.03653130080252294,0.09213867335516877,0,0,6.985553206483439,23.119287904453852,FOS;B2M
RNA metabolic process (GO:0016070),2/133,0.037551400127929575,0.09406943964250832,0,0,6.878209576682859,22.574590698130514,WTAP;ADAR
defense response to virus (GO:0051607),2/133,0.037551400127929575,0.09406943964250832,0,0,6.878209576682859,22.574590698130514,FLNA;SAMHD1
negative regulation of ATPase activity (GO:0032780),1/17,0.03840363883149023,0.09428667473910723,0,0,27.691666666666666,90.26384147630849,LTF
negative regulation of interleukin-10 production (GO:0032693),1/17,0.03840363883149023,0.09428667473910723,0,0,27.691666666666666,90.26384147630849,MMP8
positive regulation of macrophage activation (GO:0043032),1/17,0.03840363883149023,0.09428667473910723,0,0,27.691666666666666,90.26384147630849,MMP8
regulation of osteoblast proliferation (GO:0033688),1/17,0.03840363883149023,0.09428667473910723,0,0,27.691666666666666,90.26384147630849,LTF
embryo development ending in birth or egg hatching (GO:0009792),1/17,0.03840363883149023,0.09428667473910723,0,0,27.691666666666666,90.26384147630849,USP22
negative regulation of amyloid-beta formation (GO:1902430),1/17,0.03840363883149023,0.09428667473910723,0,0,27.691666666666666,90.26384147630849,SORL1
protein localization to plasma membrane (GO:0072659),2/136,0.03910201149276838,0.09528920728496373,0,0,6.723202170963365,21.793806893960955,FYB1;FLNA
regulation of transcription by RNA polymerase I (GO:0006356),1/18,0.04061718578452446,0.09528920728496373,0,0,26.061437908496732,83.48948444789488,FLNA
base conversion or substitution editing (GO:0016553),1/18,0.04061718578452446,0.09528920728496373,0,0,26.061437908496732,83.48948444789488,ADAR
negative regulation of interleukin-8 production (GO:0032717),1/18,0.04061718578452446,0.09528920728496373,0,0,26.061437908496732,83.48948444789488,BPI
negative regulation of lipid catabolic process (GO:0050995),1/18,0.04061718578452446,0.09528920728496373,0,0,26.061437908496732,83.48948444789488,SORL1
response to interferon-alpha (GO:0035455),1/18,0.04061718578452446,0.09528920728496373,0,0,26.061437908496732,83.48948444789488,ADAR
interleukin-6-mediated signaling pathway (GO:0070102),1/18,0.04061718578452446,0.09528920728496373,0,0,26.061437908496732,83.48948444789488,JAK1
intermediate filament organization (GO:0045109),1/18,0.04061718578452446,0.09528920728496373,0,0,26.061437908496732,83.48948444789488,KLHL24
intracellular estrogen receptor signaling pathway (GO:0030520),1/18,0.04061718578452446,0.09528920728496373,0,0,26.061437908496732,83.48948444789488,DEFA3
regulation of establishment or maintenance of cell polarity (GO:0032878),1/18,0.04061718578452446,0.09528920728496373,0,0,26.061437908496732,83.48948444789488,RIPOR2
positive regulation of myoblast differentiation (GO:0045663),1/18,0.04061718578452446,0.09528920728496373,0,0,26.061437908496732,83.48948444789488,RIPOR2
cellular response to glucocorticoid stimulus (GO:0071385),1/18,0.04061718578452446,0.09528920728496373,0,0,26.061437908496732,83.48948444789488,NR3C1
negative regulation of Rho protein signal transduction (GO:0035024),1/18,0.04061718578452446,0.09528920728496373,0,0,26.061437908496732,83.48948444789488,RIPOR2
leukocyte tethering or rolling (GO:0050901),1/18,0.04061718578452446,0.09528920728496373,0,0,26.061437908496732,83.48948444789488,SELL
protein localization to cell periphery (GO:1990778),2/140,0.04120707665047083,0.09636718241993021,0,0,6.5270092226613965,20.8155806159052,FYB1;FLNA
receptor-mediated endocytosis (GO:0006898),2/143,0.042813557369968766,0.09648849926643428,0,0,6.3871695680206315,20.125335565563358,ITGB2;SORL1
regulation of T cell cytokine production (GO:0002724),1/19,0.04282574798293701,0.09648849926643428,0,0,24.612345679012346,77.54404440566205,B2M
carbohydrate derivative catabolic process (GO:1901136),1/19,0.04282574798293701,0.09648849926643428,0,0,24.612345679012346,77.54404440566205,SAMHD1
histone deubiquitination (GO:0016578),1/19,0.04282574798293701,0.09648849926643428,0,0,24.612345679012346,77.54404440566205,USP22
interleukin-7-mediated signaling pathway (GO:0038111),1/19,0.04282574798293701,0.09648849926643428,0,0,24.612345679012346,77.54404440566205,JAK1
positive regulation of neutrophil chemotaxis (GO:0090023),1/19,0.04282574798293701,0.09648849926643428,0,0,24.612345679012346,77.54404440566205,RIPOR2
cellular response to interleukin-7 (GO:0098761),1/19,0.04282574798293701,0.09648849926643428,0,0,24.612345679012346,77.54404440566205,JAK1
leukocyte adhesion to vascular endothelial cell (GO:0061756),1/19,0.04282574798293701,0.09648849926643428,0,0,24.612345679012346,77.54404440566205,SELL
regulation of neuroinflammatory response (GO:0150077),1/19,0.04282574798293701,0.09648849926643428,0,0,24.612345679012346,77.54404440566205,MMP8
DNA alkylation (GO:0006305),1/19,0.04282574798293701,0.09648849926643428,0,0,24.612345679012346,77.54404440566205,FOS
DNA methylation or demethylation (GO:0044728),1/19,0.04282574798293701,0.09648849926643428,0,0,24.612345679012346,77.54404440566205,FOS
negative regulation of amyloid precursor protein catabolic process (GO:1902992),1/19,0.04282574798293701,0.09648849926643428,0,0,24.612345679012346,77.54404440566205,SORL1
protein targeting to lysosome (GO:0006622),1/20,0.045029336387548594,0.09816129672683897,0,0,23.31578947368421,72.28923154104575,SORL1
regulation of smooth muscle cell migration (GO:0014910),1/20,0.045029336387548594,0.09816129672683897,0,0,23.31578947368421,72.28923154104575,SORL1
regulation of T cell migration (GO:2000404),1/20,0.045029336387548594,0.09816129672683897,0,0,23.31578947368421,72.28923154104575,RIPOR2
glucose transmembrane transport (GO:1904659),1/20,0.045029336387548594,0.09816129672683897,0,0,23.31578947368421,72.28923154104575,SLC2A3
positive regulation of embryonic development (GO:0040019),1/20,0.045029336387548594,0.09816129672683897,0,0,23.31578947368421,72.28923154104575,CFL1
negative regulation of osteoclast differentiation (GO:0045671),1/20,0.045029336387548594,0.09816129672683897,0,0,23.31578947368421,72.28923154104575,LTF
lipopolysaccharide-mediated signaling pathway (GO:0031663),1/20,0.045029336387548594,0.09816129672683897,0,0,23.31578947368421,72.28923154104575,BPI
maintenance of protein location in nucleus (GO:0051457),1/20,0.045029336387548594,0.09816129672683897,0,0,23.31578947368421,72.28923154104575,SYNE1
toll-like receptor 4 signaling pathway (GO:0034142),1/20,0.045029336387548594,0.09816129672683897,0,0,23.31578947368421,72.28923154104575,ITGB2
cortical actin cytoskeleton organization (GO:0030866),1/20,0.045029336387548594,0.09816129672683897,0,0,23.31578947368421,72.28923154104575,LCP1
regulation of protein localization to cell periphery (GO:1904375),1/20,0.045029336387548594,0.09816129672683897,0,0,23.31578947368421,72.28923154104575,ACTB
response to cytokine (GO:0034097),2/150,0.04665195983622821,0.09943437000549911,0,0,6.082923832923833,18.644406939607435,ADAR;MCL1
regulation of cytokine production (GO:0001817),2/150,0.04665195983622821,0.09943437000549911,0,0,6.082923832923833,18.644406939607435,SRGN;LTF
cellular response to organic cyclic compound (GO:0071407),2/150,0.04665195983622821,0.09943437000549911,0,0,6.082923832923833,18.644406939607435,NR3C1;ACTB
extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),1/21,0.047227961937659255,0.09943437000549911,0,0,22.148888888888887,67.61544465949056,MCL1
purinergic nucleotide receptor signaling pathway (GO:0035590),1/21,0.047227961937659255,0.09943437000549911,0,0,22.148888888888887,67.61544465949056,CTSG
regulation of anoikis (GO:2000209),1/21,0.047227961937659255,0.09943437000549911,0,0,22.148888888888887,67.61544465949056,MCL1
histone ubiquitination (GO:0016574),1/21,0.047227961937659255,0.09943437000549911,0,0,22.148888888888887,67.61544465949056,USP22
hydrogen peroxide catabolic process (GO:0042744),1/21,0.047227961937659255,0.09943437000549911,0,0,22.148888888888887,67.61544465949056,MPO
cellular response to steroid hormone stimulus (GO:0071383),1/21,0.047227961937659255,0.09943437000549911,0,0,22.148888888888887,67.61544465949056,NR3C1
regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),1/21,0.047227961937659255,0.09943437000549911,0,0,22.148888888888887,67.61544465949056,LTF
positive regulation of T cell cytokine production (GO:0002726),1/21,0.047227961937659255,0.09943437000549911,0,0,22.148888888888887,67.61544465949056,B2M
NAD biosynthetic process (GO:0009435),1/21,0.047227961937659255,0.09943437000549911,0,0,22.148888888888887,67.61544465949056,NAMPT
negative regulation of biomineral tissue development (GO:0070168),1/22,0.049421635543190894,0.1008911289127571,0,0,21.09312169312169,63.43475777373824,SRGN
regulation of adenylate cyclase activity (GO:0045761),1/22,0.049421635543190894,0.1008911289127571,0,0,21.09312169312169,63.43475777373824,CAP1
regulation of voltage-gated calcium channel activity (GO:1901385),1/22,0.049421635543190894,0.1008911289127571,0,0,21.09312169312169,63.43475777373824,AHNAK
regulation of cardiac muscle cell membrane repolarization (GO:0099623),1/22,0.049421635543190894,0.1008911289127571,0,0,21.09312169312169,63.43475777373824,FLNA
positive regulation of granulocyte chemotaxis (GO:0071624),1/22,0.049421635543190894,0.1008911289127571,0,0,21.09312169312169,63.43475777373824,RIPOR2
positive regulation of neutrophil migration (GO:1902624),1/22,0.049421635543190894,0.1008911289127571,0,0,21.09312169312169,63.43475777373824,RIPOR2
microglial cell activation (GO:0001774),1/22,0.049421635543190894,0.1008911289127571,0,0,21.09312169312169,63.43475777373824,ITGB2
osteoclast differentiation (GO:0030316),1/22,0.049421635543190894,0.1008911289127571,0,0,21.09312169312169,63.43475777373824,GAB2
peptidyl-threonine dephosphorylation (GO:0035970),1/22,0.049421635543190894,0.1008911289127571,0,0,21.09312169312169,63.43475777373824,DUSP6
mRNA modification (GO:0016556),1/22,0.049421635543190894,0.1008911289127571,0,0,21.09312169312169,63.43475777373824,WTAP
protein localization to cell junction (GO:1902414),1/22,0.049421635543190894,0.1008911289127571,0,0,21.09312169312169,63.43475777373824,JAK1
regulation of toll-like receptor 4 signaling pathway (GO:0034143),1/23,0.05161036810287483,0.10308124872439055,0,0,20.133333333333333,59.67585824831113,LTF
negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),1/23,0.05161036810287483,0.10308124872439055,0,0,20.133333333333333,59.67585824831113,MCL1
glucose 6-phosphate metabolic process (GO:0051156),1/23,0.05161036810287483,0.10308124872439055,0,0,20.133333333333333,59.67585824831113,TKT
hexose transmembrane transport (GO:0008645),1/23,0.05161036810287483,0.10308124872439055,0,0,20.133333333333333,59.67585824831113,SLC2A3
regulation of cysteine-type endopeptidase activity (GO:2000116),1/23,0.05161036810287483,0.10308124872439055,0,0,20.133333333333333,59.67585824831113,LTF
negative regulation of signal transduction in absence of ligand (GO:1901099),1/23,0.05161036810287483,0.10308124872439055,0,0,20.133333333333333,59.67585824831113,MCL1
regulation of interferon-gamma-mediated signaling pathway (GO:0060334),1/23,0.05161036810287483,0.10308124872439055,0,0,20.133333333333333,59.67585824831113,JAK1
DNA methylation (GO:0006306),1/23,0.05161036810287483,0.10308124872439055,0,0,20.133333333333333,59.67585824831113,FOS
negative regulation of neuron differentiation (GO:0045665),1/24,0.05379417048562001,0.10601037863699517,0,0,19.257004830917875,56.28033307969816,B2M
negative regulation of ossification (GO:0030279),1/24,0.05379417048562001,0.10601037863699517,0,0,19.257004830917875,56.28033307969816,SRGN
positive regulation of neuron apoptotic process (GO:0043525),1/24,0.05379417048562001,0.10601037863699517,0,0,19.257004830917875,56.28033307969816,MCL1
lymphocyte activation involved in immune response (GO:0002285),1/24,0.05379417048562001,0.10601037863699517,0,0,19.257004830917875,56.28033307969816,LCP1
positive regulation of protein targeting to membrane (GO:0090314),1/24,0.05379417048562001,0.10601037863699517,0,0,19.257004830917875,56.28033307969816,ITGB2
regulation of neuron projection development (GO:0010975),2/165,0.05528205448031779,0.10865276133232672,0,0,5.518962632459565,15.979090785031437,CFL1;S100A9
cAMP-mediated signaling (GO:0019933),1/25,0.05597305354060756,0.10942880044049998,0,0,18.453703703703702,53.19990358724921,CAP1
regulation of neutrophil chemotaxis (GO:0090022),1/25,0.05597305354060756,0.10942880044049998,0,0,18.453703703703702,53.19990358724921,RIPOR2
glial cell development (GO:0021782),1/26,0.05814702809836536,0.1127838681487979,0,0,17.714666666666666,50.394338453793885,S100A9
negative regulation of interleukin-1 beta production (GO:0032691),1/26,0.05814702809836536,0.1127838681487979,0,0,17.714666666666666,50.394338453793885,SERPINB1
positive regulation of filopodium assembly (GO:0051491),1/26,0.05814702809836536,0.1127838681487979,0,0,17.714666666666666,50.394338453793885,RIPOR2
positive regulation of cellular component movement (GO:0051272),1/27,0.06031610495649811,0.11415091640394642,0,0,17.032478632478632,47.829859287186046,ETS1
regulation of vasculature development (GO:1901342),1/27,0.06031610495649811,0.11415091640394642,0,0,17.032478632478632,47.829859287186046,ETS1
positive regulation of erythrocyte differentiation (GO:0045648),1/27,0.06031610495649811,0.11415091640394642,0,0,17.032478632478632,47.829859287186046,ETS1
response to glucocorticoid (GO:0051384),1/27,0.06031610495649811,0.11415091640394642,0,0,17.032478632478632,47.829859287186046,NR3C1
positive regulation of mitotic cell cycle (GO:0045931),1/27,0.06031610495649811,0.11415091640394642,0,0,17.032478632478632,47.829859287186046,USP22
cellular response to cadmium ion (GO:0071276),1/27,0.06031610495649811,0.11415091640394642,0,0,17.032478632478632,47.829859287186046,FOS
positive regulation of nitric oxide biosynthetic process (GO:0045429),1/27,0.06031610495649811,0.11415091640394642,0,0,17.032478632478632,47.829859287186046,MMP8
positive regulation of toll-like receptor signaling pathway (GO:0034123),1/27,0.06031610495649811,0.11415091640394642,0,0,17.032478632478632,47.829859287186046,LTF
regulation of protein transport (GO:0051223),1/28,0.06248029490822359,0.11415091640394642,0,0,16.40082304526749,45.47790870164399,LCP1
regulation of reactive oxygen species biosynthetic process (GO:1903426),1/28,0.06248029490822359,0.11415091640394642,0,0,16.40082304526749,45.47790870164399,MMP8
carbohydrate derivative biosynthetic process (GO:1901137),1/28,0.06248029490822359,0.11415091640394642,0,0,16.40082304526749,45.47790870164399,TKT
regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),1/28,0.06248029490822359,0.11415091640394642,0,0,16.40082304526749,45.47790870164399,MCL1
positive regulation of nitric oxide metabolic process (GO:1904407),1/28,0.06248029490822359,0.11415091640394642,0,0,16.40082304526749,45.47790870164399,MMP8
cellular response to interleukin-6 (GO:0071354),1/28,0.06248029490822359,0.11415091640394642,0,0,16.40082304526749,45.47790870164399,JAK1
leukocyte cell-cell adhesion (GO:0007159),1/28,0.06248029490822359,0.11415091640394642,0,0,16.40082304526749,45.47790870164399,ITGB2
positive regulation of protein import into nucleus (GO:0042307),1/28,0.06248029490822359,0.11415091640394642,0,0,16.40082304526749,45.47790870164399,FLNA
T cell activation involved in immune response (GO:0002286),1/28,0.06248029490822359,0.11415091640394642,0,0,16.40082304526749,45.47790870164399,LCP1
regulation of multicellular organismal development (GO:2000026),1/28,0.06248029490822359,0.11415091640394642,0,0,16.40082304526749,45.47790870164399,DUSP6
protein depolymerization (GO:0051261),1/28,0.06248029490822359,0.11415091640394642,0,0,16.40082304526749,45.47790870164399,CFL1
regulation of postsynapse organization (GO:0099175),1/28,0.06248029490822359,0.11415091640394642,0,0,16.40082304526749,45.47790870164399,CFL1
protein localization to cell surface (GO:0034394),1/28,0.06248029490822359,0.11415091640394642,0,0,16.40082304526749,45.47790870164399,FLNA
protein localization to Golgi apparatus (GO:0034067),1/28,0.06248029490822359,0.11415091640394642,0,0,16.40082304526749,45.47790870164399,SORL1
protein localization to lysosome (GO:0061462),1/28,0.06248029490822359,0.11415091640394642,0,0,16.40082304526749,45.47790870164399,SORL1
positive regulation of developmental process (GO:0051094),2/177,0.0625590272579138,0.11415091640394642,0,0,5.137402597402597,14.239054844290033,CFL1;SORL1
regulation of protein targeting to membrane (GO:0090313),1/29,0.06463960869794699,0.11566264122949838,0,0,15.814285714285715,43.31418865156708,ITGB2
regulation of response to biotic stimulus (GO:0002831),1/29,0.06463960869794699,0.11566264122949838,0,0,15.814285714285715,43.31418865156708,SAMHD1
regulation of calcium ion transmembrane transporter activity (GO:1901019),1/29,0.06463960869794699,0.11566264122949838,0,0,15.814285714285715,43.31418865156708,AHNAK
response to cadmium ion (GO:0046686),1/29,0.06463960869794699,0.11566264122949838,0,0,15.814285714285715,43.31418865156708,FOS
hydrogen peroxide metabolic process (GO:0042743),1/29,0.06463960869794699,0.11566264122949838,0,0,15.814285714285715,43.31418865156708,MPO
transition metal ion homeostasis (GO:0055076),1/29,0.06463960869794699,0.11566264122949838,0,0,15.814285714285715,43.31418865156708,B2M
positive regulation of viral genome replication (GO:0045070),1/29,0.06463960869794699,0.11566264122949838,0,0,15.814285714285715,43.31418865156708,ADAR
production of miRNAs involved in gene silencing by miRNA (GO:0035196),1/29,0.06463960869794699,0.11566264122949838,0,0,15.814285714285715,43.31418865156708,ADAR
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),3/404,0.0656620327267365,0.11696873975876386,0,0,3.401902221191208,9.264177184853882,NAMPT;CYBB;ACTB
regulation of type I interferon-mediated signaling pathway (GO:0060338),1/30,0.0667940570746933,0.11696873975876386,0,0,15.268199233716475,41.317902512852925,SAMHD1
negative regulation of interleukin-1 production (GO:0032692),1/30,0.0667940570746933,0.11696873975876386,0,0,15.268199233716475,41.317902512852925,SERPINB1
heterotypic cell-cell adhesion (GO:0034113),1/30,0.0667940570746933,0.11696873975876386,0,0,15.268199233716475,41.317902512852925,ITGB2
positive regulation of protein import (GO:1904591),1/30,0.0667940570746933,0.11696873975876386,0,0,15.268199233716475,41.317902512852925,FLNA
maintenance of blood-brain barrier (GO:0035633),1/30,0.0667940570746933,0.11696873975876386,0,0,15.268199233716475,41.317902512852925,ACTB
morphogenesis of an epithelium (GO:0002009),1/30,0.0667940570746933,0.11696873975876386,0,0,15.268199233716475,41.317902512852925,ACTB
plasma membrane invagination (GO:0099024),1/30,0.0667940570746933,0.11696873975876386,0,0,15.268199233716475,41.317902512852925,ITGB2
regulation of protein localization to membrane (GO:1905475),1/30,0.0667940570746933,0.11696873975876386,0,0,15.268199233716475,41.317902512852925,ACTB
negative regulation of interleukin-6 production (GO:0032715),1/31,0.06894365075528797,0.1198808421368419,0,0,14.75851851851852,39.471152501452366,BPI
regulation of cellular senescence (GO:2000772),1/31,0.06894365075528797,0.1198808421368419,0,0,14.75851851851852,39.471152501452366,B2M
negative regulation of response to biotic stimulus (GO:0002832),1/31,0.06894365075528797,0.1198808421368419,0,0,14.75851851851852,39.471152501452366,LTF
gene silencing by miRNA (GO:0035195),1/32,0.07108840042475308,0.12217285561370353,0,0,14.281720430107526,37.75845663463361,ADAR
regulation of cell morphogenesis (GO:0022604),1/32,0.07108840042475308,0.12217285561370353,0,0,14.281720430107526,37.75845663463361,CFL1
regulation of dendritic spine morphogenesis (GO:0061001),1/32,0.07108840042475308,0.12217285561370353,0,0,14.281720430107526,37.75845663463361,CFL1
superoxide metabolic process (GO:0006801),1/32,0.07108840042475308,0.12217285561370353,0,0,14.281720430107526,37.75845663463361,CYBB
regulation of intracellular protein transport (GO:0033157),1/32,0.07108840042475308,0.12217285561370353,0,0,14.281720430107526,37.75845663463361,LCP1
actin filament bundle assembly (GO:0051017),1/33,0.07322831674647272,0.12469061307751922,0,0,13.834722222222222,36.16635856889997,LCP1
regulation of sprouting angiogenesis (GO:1903670),1/33,0.07322831674647272,0.12469061307751922,0,0,13.834722222222222,36.16635856889997,JAK1
antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),1/33,0.07322831674647272,0.12469061307751922,0,0,13.834722222222222,36.16635856889997,B2M
positive regulation of cytokine production involved in immune response (GO:0002720),1/33,0.07322831674647272,0.12469061307751922,0,0,13.834722222222222,36.16635856889997,B2M
regulation of amyloid-beta formation (GO:1902003),1/34,0.07536341037599187,0.12686460197689747,0,0,13.414814814814815,34.683110213712276,SORL1
regulation of transmembrane transport (GO:0034762),1/34,0.07536341037599187,0.12686460197689747,0,0,13.414814814814815,34.683110213712276,ACTB
positive regulation of DNA binding (GO:0043388),1/34,0.07536341037599187,0.12686460197689747,0,0,13.414814814814815,34.683110213712276,MMP8
response to steroid hormone (GO:0048545),1/34,0.07536341037599187,0.12686460197689747,0,0,13.414814814814815,34.683110213712276,NR3C1
regulation of myoblast differentiation (GO:0045661),1/34,0.07536341037599187,0.12686460197689747,0,0,13.414814814814815,34.683110213712276,RIPOR2
endomembrane system organization (GO:0010256),2/199,0.07668281267544108,0.12879226947079764,0,0,4.558606368251039,11.706855269793019,SRGN;SYNE1
negative regulation of Ras protein signal transduction (GO:0046580),1/35,0.07749369193278241,0.12898161787911305,0,0,13.019607843137255,33.298411835161396,RIPOR2
semaphorin-plexin signaling pathway (GO:0071526),1/35,0.07749369193278241,0.12898161787911305,0,0,13.019607843137255,33.298411835161396,FLNA
peptidyl-tyrosine dephosphorylation (GO:0035335),1/35,0.07749369193278241,0.12898161787911305,0,0,13.019607843137255,33.298411835161396,DUSP6
muscle cell differentiation (GO:0042692),1/35,0.07749369193278241,0.12898161787911305,0,0,13.019607843137255,33.298411835161396,SYNE1
axon guidance (GO:0007411),2/203,0.07935154632457563,0.12903194763859008,0,0,4.466983265490728,11.318743026227803,EMB;GAB2
activation of adenylate cyclase activity (GO:0007190),1/36,0.07961917202056437,0.12903194763859008,0,0,12.646984126984126,32.00319789387239,CAP1
positive regulation of bone mineralization (GO:0030501),1/36,0.07961917202056437,0.12903194763859008,0,0,12.646984126984126,32.00319789387239,LTF
negative regulation of cellular protein localization (GO:1903828),1/36,0.07961917202056437,0.12903194763859008,0,0,12.646984126984126,32.00319789387239,RIPOR2
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),1/36,0.07961917202056437,0.12903194763859008,0,0,12.646984126984126,32.00319789387239,SELL
regulation of embryonic development (GO:0045995),1/36,0.07961917202056437,0.12903194763859008,0,0,12.646984126984126,32.00319789387239,CFL1
macrophage activation (GO:0042116),1/36,0.07961917202056437,0.12903194763859008,0,0,12.646984126984126,32.00319789387239,ITGB2
positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),1/36,0.07961917202056437,0.12903194763859008,0,0,12.646984126984126,32.00319789387239,FLNA
cyclic-nucleotide-mediated signaling (GO:0019935),1/36,0.07961917202056437,0.12903194763859008,0,0,12.646984126984126,32.00319789387239,CAP1
transition metal ion transport (GO:0000041),1/36,0.07961917202056437,0.12903194763859008,0,0,12.646984126984126,32.00319789387239,LTF
positive regulation of T cell mediated immunity (GO:0002711),1/36,0.07961917202056437,0.12903194763859008,0,0,12.646984126984126,32.00319789387239,B2M
regulation of protein import into nucleus (GO:0042306),1/36,0.07961917202056437,0.12903194763859008,0,0,12.646984126984126,32.00319789387239,FLNA
regulation of transport (GO:0051049),1/37,0.08173986122317027,0.13131686400852788,0,0,12.295061728395062,30.789459546748624,ACTB
regulation of erythrocyte differentiation (GO:0045646),1/37,0.08173986122317027,0.13131686400852788,0,0,12.295061728395062,30.789459546748624,ETS1
positive regulation of myeloid cell differentiation (GO:0045639),1/37,0.08173986122317027,0.13131686400852788,0,0,12.295061728395062,30.789459546748624,ETS1
"phagocytosis, engulfment (GO:0006911)",1/37,0.08173986122317027,0.13131686400852788,0,0,12.295061728395062,30.789459546748624,ITGB2
negative regulation of innate immune response (GO:0045824),1/38,0.08385577009174108,0.13384322699308135,0,0,11.962162162162162,29.650096722737764,SAMHD1
positive regulation of potassium ion transport (GO:0043268),1/38,0.08385577009174108,0.13384322699308135,0,0,11.962162162162162,29.650096722737764,FLNA
connective tissue development (GO:0061448),1/38,0.08385577009174108,0.13384322699308135,0,0,11.962162162162162,29.650096722737764,NAMPT
regulation of receptor-mediated endocytosis (GO:0048259),1/39,0.08596690914993177,0.13545745386311212,0,0,11.646783625730993,28.57879420114118,B2M
replication fork processing (GO:0031297),1/39,0.08596690914993177,0.13545745386311212,0,0,11.646783625730993,28.57879420114118,SAMHD1
positive regulation of intracellular transport (GO:0032388),1/39,0.08596690914993177,0.13545745386311212,0,0,11.646783625730993,28.57879420114118,SORL1
cellular response to ketone (GO:1901655),1/39,0.08596690914993177,0.13545745386311212,0,0,11.646783625730993,28.57879420114118,NR3C1
regulation of intracellular transport (GO:0032386),1/39,0.08596690914993177,0.13545745386311212,0,0,11.646783625730993,28.57879420114118,LCP1
organophosphate biosynthetic process (GO:0090407),1/39,0.08596690914993177,0.13545745386311212,0,0,11.646783625730993,28.57879420114118,TKT
bone development (GO:0060348),1/40,0.08807328892912575,0.13783568803902133,0,0,11.347578347578347,27.569917287159008,LTF
carboxylic acid metabolic process (GO:0019752),1/40,0.08807328892912575,0.13783568803902133,0,0,11.347578347578347,27.569917287159008,SLC2A3
regulation of nitric oxide biosynthetic process (GO:0045428),1/40,0.08807328892912575,0.13783568803902133,0,0,11.347578347578347,27.569917287159008,MMP8
extracellular structure organization (GO:0043062),2/216,0.08822230100467807,0.13783568803902133,0,0,4.1928632115548,10.179833732134922,ITGB2;MMP8
external encapsulating structure organization (GO:0045229),2/217,0.08891669681947872,0.13833566094651534,0,0,4.173150105708245,10.099254191077135,ITGB2;MMP8
regulation of cell growth (GO:0001558),2/217,0.08891669681947872,0.13833566094651534,0,0,4.173150105708245,10.099254191077135,S100A9;S100A8
regulation of response to DNA damage stimulus (GO:2001020),1/41,0.09017491989219245,0.13912164050173326,0,0,11.063333333333333,26.618423595643765,MCL1
positive regulation of cation transmembrane transport (GO:1904064),1/41,0.09017491989219245,0.13912164050173326,0,0,11.063333333333333,26.618423595643765,FLNA
regulation of filopodium assembly (GO:0051489),1/41,0.09017491989219245,0.13912164050173326,0,0,11.063333333333333,26.618423595643765,RIPOR2
cortical cytoskeleton organization (GO:0030865),1/41,0.09017491989219245,0.13912164050173326,0,0,11.063333333333333,26.618423595643765,LCP1
ATP-dependent chromatin remodeling (GO:0043044),1/42,0.09227181253348396,0.1411777835657239,0,0,10.792953929539296,25.71978809417909,ACTB
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),1/42,0.09227181253348396,0.1411777835657239,0,0,10.792953929539296,25.71978809417909,CEACAM8
negative regulation of protein catabolic process (GO:0042177),1/42,0.09227181253348396,0.1411777835657239,0,0,10.792953929539296,25.71978809417909,FLNA
monocyte chemotaxis (GO:0002548),1/42,0.09227181253348396,0.1411777835657239,0,0,10.792953929539296,25.71978809417909,S100A12
substantia nigra development (GO:0021762),1/43,0.09436397729271122,0.14408053557709422,0,0,10.535449735449735,24.869939188170132,ACTB
positive regulation of cell population proliferation (GO:0008284),3/474,0.09520038955095364,0.1450579131508345,0,0,2.8859428232854394,6.787077347300079,NAMPT;GAB2;LTF
positive regulation of biosynthetic process (GO:0009891),1/44,0.09645142457009452,0.14546449542306092,0,0,10.289922480620156,24.065203974439605,MMP8
positive regulation of osteoblast differentiation (GO:0045669),1/44,0.09645142457009452,0.14546449542306092,0,0,10.289922480620156,24.065203974439605,LTF
positive regulation of potassium ion transmembrane transport (GO:1901381),1/44,0.09645142457009452,0.14546449542306092,0,0,10.289922480620156,24.065203974439605,FLNA
positive regulation of receptor-mediated endocytosis (GO:0048260),1/44,0.09645142457009452,0.14546449542306092,0,0,10.289922480620156,24.065203974439605,B2M
mitotic spindle assembly (GO:0090307),1/44,0.09645142457009452,0.14546449542306092,0,0,10.289922480620156,24.065203974439605,FLNA
negative regulation of T cell activation (GO:0050868),1/45,0.09853416477511664,0.14761814296059614,0,0,10.055555555555555,23.30226117880883,RIPOR2
regulation of insulin receptor signaling pathway (GO:0046626),1/45,0.09853416477511664,0.14761814296059614,0,0,10.055555555555555,23.30226117880883,SORL1
protein deacetylation (GO:0006476),1/45,0.09853416477511664,0.14761814296059614,0,0,10.055555555555555,23.30226117880883,FLNA
regulation of autophagy (GO:0010506),2/231,0.09880796517574712,0.14761814296059614,0,0,3.9152441445017865,9.062134274468654,PSAP;MCL1
positive regulation of gene expression (GO:0010628),3/482,0.09887818777468889,0.14761814296059614,0,0,2.8365781424479293,6.563463458868195,MMP8;ETS1;ACTB
regulation of gene expression (GO:0010468),5/1079,0.10051752765948768,0.14811239429030207,0,0,2.143797974292592,4.925211121040805,AHNAK;NR3C1;MMP8;ETS1;LTF
regulation of cellular protein localization (GO:1903827),1/46,0.1006122083000428,0.14811239429030207,0,0,9.831604938271605,22.57810056486298,LCP1
positive regulation of nucleocytoplasmic transport (GO:0046824),1/46,0.1006122083000428,0.14811239429030207,0,0,9.831604938271605,22.57810056486298,FLNA
positive regulation of organelle assembly (GO:1902117),1/46,0.1006122083000428,0.14811239429030207,0,0,9.831604938271605,22.57810056486298,LCP1
negative regulation of tumor necrosis factor production (GO:0032720),1/46,0.1006122083000428,0.14811239429030207,0,0,9.831604938271605,22.57810056486298,BPI
positive regulation of response to stimulus (GO:0048584),1/46,0.1006122083000428,0.14811239429030207,0,0,9.831604938271605,22.57810056486298,B2M
vesicle organization (GO:0016050),1/46,0.1006122083000428,0.14811239429030207,0,0,9.831604938271605,22.57810056486298,SRGN
positive regulation of cell-cell adhesion (GO:0022409),1/47,0.10268556547660973,0.15026659977666254,0,0,9.617391304347827,21.889987798811458,JAK1
glycosphingolipid metabolic process (GO:0006687),1/47,0.10268556547660973,0.15026659977666254,0,0,9.617391304347827,21.889987798811458,PSAP
regulation of DNA binding (GO:0051101),1/47,0.10268556547660973,0.15026659977666254,0,0,9.617391304347827,21.889987798811458,MMP8
positive regulation of blood vessel endothelial cell migration (GO:0043536),1/48,0.10475424665272434,0.15179095740463389,0,0,9.412293144208038,21.235433925545344,ETS1
positive regulation of endocytosis (GO:0045807),1/48,0.10475424665272434,0.15179095740463389,0,0,9.412293144208038,21.235433925545344,B2M
negative regulation of MAP kinase activity (GO:0043407),1/48,0.10475424665272434,0.15179095740463389,0,0,9.412293144208038,21.235433925545344,SORL1
regulation of interleukin-10 production (GO:0032653),1/48,0.10475424665272434,0.15179095740463389,0,0,9.412293144208038,21.235433925545344,MMP8
nucleus organization (GO:0006997),1/48,0.10475424665272434,0.15179095740463389,0,0,9.412293144208038,21.235433925545344,SYNE1
negative regulation of catabolic process (GO:0009895),1/49,0.10681826213767642,0.15387659984355337,0,0,9.21574074074074,20.612168790008823,FLNA
adherens junction organization (GO:0034332),1/49,0.10681826213767642,0.15387659984355337,0,0,9.21574074074074,20.612168790008823,ACTB
receptor internalization (GO:0031623),1/49,0.10681826213767642,0.15387659984355337,0,0,9.21574074074074,20.612168790008823,ITGB2
actin polymerization or depolymerization (GO:0008154),1/50,0.10887762220856746,0.15532927183809142,0,0,9.02721088435374,20.018117808730278,CFL1
positive regulation of cell morphogenesis involved in differentiation (GO:0010770),1/50,0.10887762220856746,0.15532927183809142,0,0,9.02721088435374,20.018117808730278,FLNA
negative regulation of ERK1 and ERK2 cascade (GO:0070373),1/50,0.10887762220856746,0.15532927183809142,0,0,9.02721088435374,20.018117808730278,DUSP6
regulation of cellular component movement (GO:0051270),1/50,0.10887762220856746,0.15532927183809142,0,0,9.02721088435374,20.018117808730278,ETS1
iron ion transport (GO:0006826),1/50,0.10887762220856746,0.15532927183809142,0,0,9.02721088435374,20.018117808730278,LTF
regulation of substrate adhesion-dependent cell spreading (GO:1900024),1/51,0.11093233713692385,0.15734932273356378,0,0,8.846222222222222,19.451381614691524,FLNA
inositol lipid-mediated signaling (GO:0048017),1/51,0.11093233713692385,0.15734932273356378,0,0,8.846222222222222,19.451381614691524,GAB2
intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),1/51,0.11093233713692385,0.15734932273356378,0,0,8.846222222222222,19.451381614691524,MCL1
positive regulation of nucleic acid-templated transcription (GO:1903508),3/511,0.11268688073272012,0.1587338522746195,0,0,2.67066471342245,5.830441034144349,USP22;FOS;ETS1
negative regulation of BMP signaling pathway (GO:0030514),1/52,0.11298241718058168,0.1587338522746195,0,0,8.672331154684096,18.910218175570737,SORL1
glycolipid metabolic process (GO:0006664),1/52,0.11298241718058168,0.1587338522746195,0,0,8.672331154684096,18.910218175570737,PSAP
negative regulation of protein metabolic process (GO:0051248),1/52,0.11298241718058168,0.1587338522746195,0,0,8.672331154684096,18.910218175570737,FLNA
negative regulation of protein-containing complex assembly (GO:0031333),1/52,0.11298241718058168,0.1587338522746195,0,0,8.672331154684096,18.910218175570737,SORL1
positive regulation of signal transduction (GO:0009967),2/252,0.1141927466343748,0.1601298667225863,0,0,3.5825454545454547,7.773648943224575,FLNA;SORL1
negative regulation of cysteine-type endopeptidase activity (GO:2000117),1/53,0.11502787253673812,0.16038792038613106,0,0,8.505128205128205,18.393027043859387,LTF
IRE1-mediated unfolded protein response (GO:0036498),1/53,0.11502787253673812,0.16038792038613106,0,0,8.505128205128205,18.393027043859387,TLN1
positive regulation of NIK/NF-kappaB signaling (GO:1901224),1/53,0.11502787253673812,0.16038792038613106,0,0,8.505128205128205,18.393027043859387,MMP8
"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",1/54,0.11706871342498994,0.16201082251136248,0,0,8.344234800838574,17.89833543767599,WTAP
regulation of cyclin-dependent protein kinase activity (GO:1904029),1/54,0.11706871342498994,0.16201082251136248,0,0,8.344234800838574,17.89833543767599,ACTB
negative regulation of viral genome replication (GO:0045071),1/54,0.11706871342498994,0.16201082251136248,0,0,8.344234800838574,17.89833543767599,LTF
regulation of potassium ion transmembrane transport (GO:1901379),1/54,0.11706871342498994,0.16201082251136248,0,0,8.344234800838574,17.89833543767599,FLNA
positive regulation of cell differentiation (GO:0045597),2/258,0.11869800264545177,0.16390792935844256,0,0,3.4975142045454546,7.453807155802997,RIPOR2;LTF
negative regulation of cytokine-mediated signaling pathway (GO:0001960),1/55,0.11910495002095219,0.16390792935844256,0,0,8.189300411522634,17.42478592911776,SAMHD1
regulation of blood vessel endothelial cell migration (GO:0043535),1/55,0.11910495002095219,0.16390792935844256,0,0,8.189300411522634,17.42478592911776,ETS1
Rho protein signal transduction (GO:0007266),1/56,0.12113659247839492,0.16639394394337148,0,0,8.04,16.971125513183228,CFL1
regulation of bone mineralization (GO:0030500),1/57,0.12316365091495214,0.1682401811943616,0,0,7.896031746031746,16.536195888856938,SRGN
"positive regulation of gene expression, epigenetic (GO:0045815)",1/57,0.12316365091495214,0.1682401811943616,0,0,7.896031746031746,16.536195888856938,ACTB
carboxylic acid transport (GO:0046942),1/57,0.12316365091495214,0.1682401811943616,0,0,7.896031746031746,16.536195888856938,PSAP
receptor metabolic process (GO:0043112),1/58,0.12518613547672552,0.17005984212739,0,0,7.757115009746589,16.11892479212372,ITGB2
RNA modification (GO:0009451),1/58,0.12518613547672552,0.17005984212739,0,0,7.757115009746589,16.11892479212372,ADAR
positive regulation of protein binding (GO:0032092),1/58,0.12518613547672552,0.17005984212739,0,0,7.757115009746589,16.11892479212372,B2M
protein deubiquitination (GO:0016579),2/267,0.12553943098383155,0.17022686146247984,0,0,3.3771869639794168,7.008120149275217,USP22;ACTB
negative regulation of autophagy (GO:0010507),1/59,0.12720405622576708,0.1718533776066579,0,0,7.622988505747126,15.718318266429916,MCL1
response to reactive oxygen species (GO:0000302),1/59,0.12720405622576708,0.1718533776066579,0,0,7.622988505747126,15.718318266429916,FOS
homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),1/60,0.1292174232451343,0.1736212286875532,0,0,7.493408662900189,15.333453732333883,EMB
RNA methylation (GO:0001510),1/60,0.1292174232451343,0.1736212286875532,0,0,7.493408662900189,15.333453732333883,WTAP
cellular response to chemokine (GO:1990869),1/60,0.1292174232451343,0.1736212286875532,0,0,7.493408662900189,15.333453732333883,RIPOR2
positive regulation of MAPK cascade (GO:0043410),2/274,0.1309260570795251,0.17559774261664074,0,0,3.2891042780748663,6.687152126120194,S100A12;MMP8
iron ion homeostasis (GO:0055072),1/61,0.13122624658182752,0.17568151489849737,0,0,7.368148148148149,14.96347378325842,B2M
protein modification by small protein removal (GO:0070646),2/276,0.1324751343157484,0.17703277442918275,0,0,3.2647644326476444,6.599265267556147,USP22;ACTB
"positive regulation of transcription, DNA-templated (GO:0045893)",5/1183,0.13400815476743907,0.17875817034862362,0,0,1.943765787403205,3.906686656581266,USP22;NAMPT;FOS;NR3C1;ETS1
actin cytoskeleton reorganization (GO:0031532),1/63,0.13523030227867788,0.17877494344175843,0,0,7.129749103942652,14.265030973088258,FLNA
negative regulation of peptidase activity (GO:0010466),1/63,0.13523030227867788,0.17877494344175843,0,0,7.129749103942652,14.265030973088258,SERPINB1
cellular response to reactive oxygen species (GO:0034614),1/63,0.13523030227867788,0.17877494344175843,0,0,7.129749103942652,14.265030973088258,FOS
neuropeptide signaling pathway (GO:0007218),1/63,0.13523030227867788,0.17877494344175843,0,0,7.129749103942652,14.265030973088258,SORL1
positive regulation of viral process (GO:0048524),1/63,0.13523030227867788,0.17877494344175843,0,0,7.129749103942652,14.265030973088258,ADAR
negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),1/64,0.13722555462281913,0.18076592667783128,0,0,7.016225749559083,13.935131696937612,MCL1
regulation of innate immune response (GO:0045088),1/64,0.13722555462281913,0.18076592667783128,0,0,7.016225749559083,13.935131696937612,SAMHD1
regulation of RNA metabolic process (GO:0051252),1/65,0.13921630325203724,0.18241285124690695,0,0,6.90625,13.617235566553108,AHNAK
regulation of cellular catabolic process (GO:0031329),1/65,0.13921630325203724,0.18241285124690695,0,0,6.90625,13.617235566553108,PSAP
protein autoubiquitination (GO:0051865),1/65,0.13921630325203724,0.18241285124690695,0,0,6.90625,13.617235566553108,KLHL24
positive regulation of cell cycle (GO:0045787),1/66,0.1412025581168882,0.18468794769624847,0,0,6.79965811965812,13.31073764113508,USP22
positive regulation of catabolic process (GO:0009896),1/67,0.14318432912272544,0.18661943425342875,0,0,6.696296296296296,13.015071906709133,SORL1
vascular endothelial growth factor receptor signaling pathway (GO:0048010),1/67,0.14318432912272544,0.18661943425342875,0,0,6.696296296296296,13.015071906709133,CYBB
positive regulation of protein localization to nucleus (GO:1900182),1/68,0.14516162617874134,0.1888634537783272,0,0,6.596019900497512,12.729708236779256,FLNA
positive regulation of MAP kinase activity (GO:0043406),1/69,0.14713445914858997,0.19109378789245693,0,0,6.498692810457516,12.454149635186281,S100A12
positive regulation of cell-substrate adhesion (GO:0010811),1/70,0.14910283790143838,0.19297197409660766,0,0,6.404186795491143,12.187929722777866,FLNA
negative regulation of viral process (GO:0048525),1/70,0.14910283790143838,0.19297197409660766,0,0,6.404186795491143,12.187929722777866,LTF
Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),1/71,0.15106677225376997,0.19381657065197225,0,0,6.312380952380952,11.93061045195859,ACTB
regulation of endopeptidase activity (GO:0052548),1/71,0.15106677225376997,0.19381657065197225,0,0,6.312380952380952,11.93061045195859,SERPINB1
nucleic acid metabolic process (GO:0090304),1/71,0.15106677225376997,0.19381657065197225,0,0,6.312380952380952,11.93061045195859,WTAP
phosphatidylinositol-mediated signaling (GO:0048015),1/71,0.15106677225376997,0.19381657065197225,0,0,6.312380952380952,11.93061045195859,GAB2
myeloid leukocyte differentiation (GO:0002573),1/71,0.15106677225376997,0.19381657065197225,0,0,6.312380952380952,11.93061045195859,GAB2
extrinsic apoptotic signaling pathway (GO:0097191),1/72,0.15302627203462094,0.1953133247557597,0,0,6.223161189358373,11.68178001613074,MCL1
Fc-gamma receptor signaling pathway (GO:0038094),1/72,0.15302627203462094,0.1953133247557597,0,0,6.223161189358373,11.68178001613074,ACTB
negative regulation of epithelial cell proliferation (GO:0050680),1/72,0.15302627203462094,0.1953133247557597,0,0,6.223161189358373,11.68178001613074,B2M
MAPK cascade (GO:0000165),2/303,0.1537837626773474,0.19577985545434426,0,0,2.967834491090305,5.556402888532314,DUSP6;JAK1
positive regulation of transcription by RNA polymerase II (GO:0045944),4/908,0.15489526545039176,0.19577985545434426,0,0,2.006953223767383,3.7429799991760895,NAMPT;FOS;NR3C1;ETS1
regulation of Rho protein signal transduction (GO:0035023),1/73,0.15498134701054317,0.19577985545434426,0,0,6.13641975308642,11.44105094540804,RIPOR2
negative regulation of cell adhesion (GO:0007162),1/73,0.15498134701054317,0.19577985545434426,0,0,6.13641975308642,11.44105094540804,RIPOR2
positive regulation of JNK cascade (GO:0046330),1/73,0.15498134701054317,0.19577985545434426,0,0,6.13641975308642,11.44105094540804,MMP8
insulin receptor signaling pathway (GO:0008286),1/73,0.15498134701054317,0.19577985545434426,0,0,6.13641975308642,11.44105094540804,NAMPT
Fc receptor mediated stimulatory signaling pathway (GO:0002431),1/74,0.15693200698822565,0.19723257340867137,0,0,6.052054794520548,11.20805835747445,ACTB
regulation of cytokine-mediated signaling pathway (GO:0001959),1/74,0.15693200698822565,0.19723257340867137,0,0,6.052054794520548,11.20805835747445,JAK1
mitotic nuclear division (GO:0140014),1/74,0.15693200698822565,0.19723257340867137,0,0,6.052054794520548,11.20805835747445,FLNA
positive regulation of immune response (GO:0050778),1/75,0.15887826166448996,0.19933961862488636,0,0,5.96996996996997,10.982458365229922,ITGB2
regulation of RNA splicing (GO:0043484),1/76,0.16082012081952446,0.19974129291702283,0,0,5.890074074074074,10.763926603538268,AHNAK
regulation of BMP signaling pathway (GO:0030510),1/76,0.16082012081952446,0.19974129291702283,0,0,5.890074074074074,10.763926603538268,SORL1
positive regulation of interleukin-6 production (GO:0032755),1/76,0.16082012081952446,0.19974129291702283,0,0,5.890074074074074,10.763926603538268,MMP8
cell morphogenesis involved in neuron differentiation (GO:0048667),1/76,0.16082012081952446,0.19974129291702283,0,0,5.890074074074074,10.763926603538268,ACTB
cellular response to hormone stimulus (GO:0032870),1/76,0.16082012081952446,0.19974129291702283,0,0,5.890074074074074,10.763926603538268,NR3C1
water-soluble vitamin metabolic process (GO:0006767),1/76,0.16082012081952446,0.19974129291702283,0,0,5.890074074074074,10.763926603538268,SLC2A3
positive regulation of tumor necrosis factor production (GO:0032760),1/77,0.16275759412626153,0.20180849338809947,0,0,5.812280701754386,10.552156890784307,MMP8
negative regulation of apoptotic signaling pathway (GO:2001234),1/78,0.16469069128213965,0.20352244290552038,0,0,5.7365079365079366,10.346859986896192,MCL1
negative regulation of protein serine/threonine kinase activity (GO:0071901),1/78,0.16469069128213965,0.20352244290552038,0,0,5.7365079365079366,10.346859986896192,SORL1
recombinational repair (GO:0000725),1/79,0.16661942196018775,0.2048781245067866,0,0,5.662678062678062,10.147762456924237,SAMHD1
axon development (GO:0061564),1/79,0.16661942196018775,0.2048781245067866,0,0,5.662678062678062,10.147762456924237,ACTB
regulation of ion transport (GO:0043269),1/79,0.16661942196018775,0.2048781245067866,0,0,5.662678062678062,10.147762456924237,B2M
negative regulation of cellular component organization (GO:0051129),1/80,0.16854379579764434,0.20553443084894252,0,0,5.590717299578059,9.954605622805227,SORL1
negative regulation of cellular response to growth factor stimulus (GO:0090288),1/80,0.16854379579764434,0.20553443084894252,0,0,5.590717299578059,9.954605622805227,SORL1
negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),1/80,0.16854379579764434,0.20553443084894252,0,0,5.590717299578059,9.954605622805227,MCL1
regulation of NIK/NF-kappaB signaling (GO:1901222),1/80,0.16854379579764434,0.20553443084894252,0,0,5.590717299578059,9.954605622805227,MMP8
regulation of protein localization to plasma membrane (GO:1903076),1/80,0.16854379579764434,0.20553443084894252,0,0,5.590717299578059,9.954605622805227,ACTB
negative regulation of gene expression (GO:0010629),2/322,0.16916332577758678,0.20595007866496975,0,0,2.7889204545454547,4.955606556639288,SRGN;MMP8
regulation of interleukin-8 production (GO:0032677),1/81,0.17046382240589766,0.20685183047283803,0,0,5.520555555555555,9.767144595990155,BPI
positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),1/81,0.17046382240589766,0.20685183047283803,0,0,5.520555555555555,9.767144595990155,MMP8
regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),1/82,0.17237951139549326,0.2078115153691183,0,0,5.452126200274348,9.585147383985147,ACTB
cell-cell junction organization (GO:0045216),1/82,0.17237951139549326,0.2078115153691183,0,0,5.452126200274348,9.585147383985147,TLN1
"regulation of gene expression, epigenetic (GO:0040029)",1/82,0.17237951139549326,0.2078115153691183,0,0,5.452126200274348,9.585147383985147,ACTB
ephrin receptor signaling pathway (GO:0048013),1/82,0.17237951139549326,0.2078115153691183,0,0,5.452126200274348,9.585147383985147,ACTB
regulation of defense response (GO:0031347),1/83,0.1742908723742125,0.20875357323264676,0,0,5.385365853658537,9.408394065633235,SAMHD1
positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),1/83,0.1742908723742125,0.20875357323264676,0,0,5.385365853658537,9.408394065633235,RIPOR2
regulation of interleukin-1 beta production (GO:0032651),1/83,0.1742908723742125,0.20875357323264676,0,0,5.385365853658537,9.408394065633235,SERPINB1
regulation of osteoblast differentiation (GO:0045667),1/83,0.1742908723742125,0.20875357323264676,0,0,5.385365853658537,9.408394065633235,LTF
spindle assembly (GO:0051225),1/84,0.17619791485755867,0.210355830500381,0,0,5.320214190093708,9.23667603092824,FLNA
vascular transport (GO:0010232),1/84,0.17619791485755867,0.210355830500381,0,0,5.320214190093708,9.23667603092824,SLC2A3
positive regulation of protein catabolic process (GO:0045732),1/85,0.1781006483840695,0.21228448250939896,0,0,5.256613756613756,9.069795270996941,SORL1
positive regulation of cytokine production (GO:0001819),2/335,0.1798375041753609,0.21317199036688356,0,0,2.6782691782691783,4.595110688679952,MMP8;SORL1
negative regulation of cellular amide metabolic process (GO:0034249),1/86,0.17999908252900587,0.21317199036688356,0,0,5.1945098039215685,8.907563723274029,SORL1
positive regulation of endothelial cell migration (GO:0010595),1/86,0.17999908252900587,0.21317199036688356,0,0,5.1945098039215685,8.907563723274029,ETS1
transport across blood-brain barrier (GO:0150104),1/86,0.17999908252900587,0.21317199036688356,0,0,5.1945098039215685,8.907563723274029,SLC2A3
sensory perception of mechanical stimulus (GO:0050954),1/88,0.1837830905392396,0.21695799346405445,0,0,5.074584929757344,8.596342164509942,RIPOR2
positive regulation of neuron projection development (GO:0010976),1/88,0.1837830905392396,0.21695799346405445,0,0,5.074584929757344,8.596342164509942,S100A9
regulation of cation channel activity (GO:2001257),1/89,0.1856686833588573,0.2177923127018977,0,0,5.016666666666667,8.44702052052336,AHNAK
regulation of endothelial cell migration (GO:0010594),1/89,0.1856686833588573,0.2177923127018977,0,0,5.016666666666667,8.44702052052336,ETS1
transforming growth factor beta receptor signaling pathway (GO:0007179),1/89,0.1856686833588573,0.2177923127018977,0,0,5.016666666666667,8.44702052052336,FOS
post-Golgi vesicle-mediated transport (GO:0006892),1/89,0.1856686833588573,0.2177923127018977,0,0,5.016666666666667,8.44702052052336,SORL1
"regulation of mRNA splicing, via spliceosome (GO:0048024)",1/90,0.18755001462176596,0.21965049256019817,0,0,4.960049937578027,8.30168381449168,WTAP
positive regulation of multicellular organismal process (GO:0051240),2/345,0.18812039409988746,0.21996989120224184,0,0,2.5988603233501193,4.341846102966184,CFL1;SORL1
sensory perception of sound (GO:0007605),1/91,0.18942709377430825,0.22079908880002178,0,0,4.904691358024691,8.160185435636516,RIPOR2
positive regulation of transport (GO:0051050),1/91,0.18942709377430825,0.22079908880002178,0,0,4.904691358024691,8.160185435636516,ACTB
T cell activation (GO:0042110),1/92,0.1912999301686515,0.2219319441046051,0,0,4.85054945054945,8.022385666002098,LCP1
regulation of lipid metabolic process (GO:0019216),1/92,0.1912999301686515,0.2219319441046051,0,0,4.85054945054945,8.022385666002098,PSAP
regulation of peptidyl-tyrosine phosphorylation (GO:0050730),1/92,0.1912999301686515,0.2219319441046051,0,0,4.85054945054945,8.022385666002098,ITGB2
cellular response to DNA damage stimulus (GO:0006974),2/350,0.19228288819832048,0.22272265576576622,0,0,2.5608672936259143,4.222326278093028,SAMHD1;MCL1
regulation of epithelial cell proliferation (GO:0050678),1/93,0.1931685332408311,0.22339835064941188,0,0,4.797584541062802,7.888151282241151,B2M
negative regulation of cell death (GO:0060548),1/94,0.19503291231959316,0.2248507366679865,0,0,4.745758661887694,7.757355193343563,SORL1
positive regulation of epithelial cell migration (GO:0010634),1/94,0.19503291231959316,0.2248507366679865,0,0,4.745758661887694,7.757355193343563,ETS1
gene expression (GO:0010467),2/356,0.19729485787294734,0.22710420555780075,0,0,2.516692347200822,4.084732435019228,ADAR;SORL1
double-strand break repair via homologous recombination (GO:0000724),1/97,0.20060079887425283,0.2305505293438147,0,0,4.596759259259259,7.384410686337352,SAMHD1
negative regulation of neuron death (GO:1901215),1/98,0.2024483751456497,0.23231265408794277,0,0,4.54914089347079,7.266207923932136,SORL1
positive regulation of stress-activated MAPK cascade (GO:0032874),1/99,0.2042917739097955,0.23406452855711454,0,0,4.502494331065759,7.150888703946834,MMP8
cell-matrix adhesion (GO:0007160),1/100,0.20613100438312365,0.23580621089648357,0,0,4.45679012345679,7.038356248208516,ITGB2
cellular response to chemical stress (GO:0062197),1/101,0.20796607582317628,0.23717118832303594,0,0,4.412,6.928517925895823,CYBB
positive regulation of protein localization to membrane (GO:1905477),1/101,0.20796607582317628,0.23717118832303594,0,0,4.412,6.928517925895823,ITGB2
intrinsic apoptotic signaling pathway (GO:0097193),1/102,0.20979699739375907,0.2385230478061353,0,0,4.368096809680968,6.821285040264925,MCL1
positive regulation of vasculature development (GO:1904018),1/102,0.20979699739375907,0.2385230478061353,0,0,4.368096809680968,6.821285040264925,ETS1
cellular response to organonitrogen compound (GO:0071417),1/103,0.2116237782804449,0.23986192047430796,0,0,4.325054466230937,6.7165726231791085,ACTB
chromatin remodeling (GO:0006338),1/103,0.2116237782804449,0.23986192047430796,0,0,4.325054466230937,6.7165726231791085,ACTB
regulation of JNK cascade (GO:0046328),1/105,0.21526495458182926,0.24361531613471948,0,0,4.2414529914529915,6.514386838497086,MMP8
negative regulation of cell population proliferation (GO:0008285),2/379,0.21665475972488732,0.24481325296130235,0,0,2.3603809983120327,3.6100850988020996,ETS1;B2M
protein processing (GO:0016485),1/106,0.21707936826802343,0.24491855442758675,0,0,4.200846560846561,6.416760522811149,SRGN
negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),1/108,0.22069589219613858,0.2484586338562505,0,0,4.121910695742471,6.2280816665872045,SORL1
positive regulation of macromolecule metabolic process (GO:0010604),2/384,0.22088947556638236,0.2484586338562505,0,0,2.3288910042836743,3.5168415681103093,MMP8;ETS1
histone modification (GO:0016570),1/114,0.23144768738022192,0.25993896804556843,0,0,3.9018682399213374,5.709999458304172,USP22
positive regulation of protein metabolic process (GO:0051247),1/115,0.23322548859490452,0.26153814274906595,0,0,3.867446393762183,5.6300332746081745,SORL1
phosphorylation (GO:0016310),2/400,0.23448864269537908,0.2623330182144342,0,0,2.2334399269072636,3.2392654086626194,CTSG;JAK1
regulation of protein-containing complex assembly (GO:0043254),1/116,0.23499926665487883,0.2623330182144342,0,0,3.833623188405797,5.551749154521461,SORL1
sphingolipid metabolic process (GO:0006665),1/116,0.23499926665487883,0.2623330182144342,0,0,3.833623188405797,5.551749154521461,PSAP
positive regulation of cell projection organization (GO:0031346),1/117,0.23676903040121397,0.26390997506258995,0,0,3.800383141762452,5.47509862046217,S100A9
regulation of cellular response to stress (GO:0080135),1/118,0.23853478876934758,0.26468049384466646,0,0,3.7677113010446344,5.400034976248376,MCL1
negative regulation of response to external stimulus (GO:0032102),1/118,0.23853478876934758,0.26468049384466646,0,0,3.7677113010446344,5.400034976248376,LTF
positive regulation of protein-containing complex assembly (GO:0031334),1/118,0.23853478876934758,0.26468049384466646,0,0,3.7677113010446344,5.400034976248376,LCP1
regulation of cell migration (GO:0030334),2/408,0.24131055149755654,0.26735906680164057,0,0,2.188535602328706,3.111376678221433,FLNA;SORL1
cytoskeleton organization (GO:0007010),1/120,0.24205432476369537,0.26778165568917794,0,0,3.704014939309057,5.254490018618861,CFL1
protein targeting (GO:0006605),1/125,0.250783688414426,0.2770241341379085,0,0,3.553763440860215,4.915439470317898,SORL1
organelle organization (GO:0006996),2/420,0.2515636693396783,0.27747097260003323,0,0,2.124401913875598,2.931800327294394,CFL1;SYNE1
regulation of cell population proliferation (GO:0042127),3/764,0.2565482735698598,0.2825472044234373,0,0,1.759588057329707,2.3938112159671636,NAMPT;GAB2;ETS1
positive regulation of macromolecule biosynthetic process (GO:0010557),1/129,0.25769629607017885,0.2825483127535047,0,0,3.442013888888889,4.667279738567,NAMPT
cellular response to insulin stimulus (GO:0032869),1/129,0.25769629607017885,0.2825483127535047,0,0,3.442013888888889,4.667279738567,NAMPT
muscle contraction (GO:0006936),1/129,0.25769629607017885,0.2825483127535047,0,0,3.442013888888889,4.667279738567,TLN1
regulation of response to external stimulus (GO:0032101),1/130,0.2594146756143242,0.28317200188919583,0,0,3.4151593453919036,4.608168194413571,SAMHD1
Golgi organization (GO:0007030),1/130,0.2594146756143242,0.28317200188919583,0,0,3.4151593453919036,4.608168194413571,SYNE1
regulation of primary metabolic process (GO:0080090),1/130,0.2594146756143242,0.28317200188919583,0,0,3.4151593453919036,4.608168194413571,PSAP
regulation of cell adhesion (GO:0030155),1/133,0.26454649880748893,0.28749979796872693,0,0,3.337037037037037,4.437385770595149,RIPOR2
regulation of cell motility (GO:2000145),1/133,0.26454649880748893,0.28749979796872693,0,0,3.337037037037037,4.437385770595149,FLNA
transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),1/133,0.26454649880748893,0.28749979796872693,0,0,3.337037037037037,4.437385770595149,FOS
protein dephosphorylation (GO:0006470),1/139,0.2747059975928274,0.2981023968004397,0,0,3.1909822866344606,4.1229209578945945,DUSP6
neuron projection morphogenesis (GO:0048812),1/140,0.2763858462398367,0.29904705764456707,0,0,3.1678657074340526,4.0737403357741835,ACTB
transcription initiation from RNA polymerase II promoter (GO:0006367),1/140,0.2763858462398367,0.29904705764456707,0,0,3.1678657074340526,4.0737403357741835,NR3C1
Ras protein signal transduction (GO:0007265),1/142,0.27973413304863926,0.30178616689480936,0,0,3.122616233254531,3.977949693868639,CFL1
protein localization to organelle (GO:0033365),1/142,0.27973413304863926,0.30178616689480936,0,0,3.122616233254531,3.977949693868639,SORL1
negative regulation of DNA-binding transcription factor activity (GO:0043433),1/143,0.2814025880638636,0.3031436043428501,0,0,3.1004694835680753,3.9312989960385463,FLNA
positive regulation of transferase activity (GO:0051347),1/148,0.2896883145842489,0.31161523213647735,0,0,2.9942554799697656,3.709731962420885,SORL1
positive regulation of hydrolase activity (GO:0051345),1/149,0.2913342085625659,0.3129302036740352,0,0,2.973873873873874,3.667631625100376,PSAP
dephosphorylation (GO:0016311),1/153,0.2978805565797009,0.3194974329642946,0,0,2.8950292397660817,3.5060618977899556,DUSP6
positive regulation of protein kinase activity (GO:0045860),1/154,0.2995078778024667,0.320777277820323,0,0,2.8759622367465503,3.4673019425835068,LTF
mitotic spindle organization (GO:0007052),1/157,0.3043677348593961,0.32551050081200245,0,0,2.82022792022792,3.3547137209830717,FLNA
cellular response to growth factor stimulus (GO:0071363),1/158,0.3059803455767096,0.3258205697135279,0,0,2.802123142250531,3.3183706439641787,NR3C1
skeletal system development (GO:0001501),1/158,0.3059803455767096,0.3258205697135279,0,0,2.802123142250531,3.3183706439641787,RFLNB
T cell receptor signaling pathway (GO:0050852),1/158,0.3059803455767096,0.3258205697135279,0,0,2.802123142250531,3.3183706439641787,FYB1
positive regulation of protein kinase B signaling (GO:0051897),1/161,0.31079626654489523,0.3304725769448598,0,0,2.7491666666666665,3.212724752591863,GAB2
double-strand break repair (GO:0006302),1/164,0.3155794904528524,0.33507649920209465,0,0,2.698159509202454,3.1119079103686236,SAMHD1
protein phosphorylation (GO:0006468),2/496,0.31655905904333287,0.3356343538493874,0,0,1.7905778432094221,2.059604024816365,CTSG;JAK1
adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),1/165,0.31716666998745746,0.3357968038978955,0,0,2.6815718157181574,3.0793236525859244,PSAP
regulation of MAPK cascade (GO:0043408),1/166,0.31875024868156443,0.3369906062599086,0,0,2.665185185185185,3.0472325582161406,MMP8
"DNA-templated transcription, initiation (GO:0006352)",1/168,0.3219066354096492,0.33984143366818675,0,0,2.6330006653359947,2.984489738993239,NR3C1
regulation of mitotic cell cycle (GO:0007346),1/178,0.33747521614547465,0.3557691650948727,0,0,2.482988072818581,2.697178581978964,USP22
protein stabilization (GO:0050821),1/179,0.33901270430157027,0.35637324107946006,0,0,2.4689138576779026,2.6706678109547566,FLNA
RNA processing (GO:0006396),1/179,0.33901270430157027,0.35637324107946006,0,0,2.4689138576779026,2.6706678109547566,ADAR
positive regulation of cellular biosynthetic process (GO:0031328),1/180,0.340546701830439,0.35747729069985007,0,0,2.4549968963376783,2.6445300368822386,MMP8
protein ubiquitination (GO:0016567),2/525,0.34114207445905914,0.35759431634786487,0,0,1.6887710759603685,1.8161994047908163,USP22;KLHL24
antigen receptor-mediated signaling pathway (GO:0050851),1/185,0.3481646013784857,0.36443858416246594,0,0,2.38768115942029,2.5191944432437494,FYB1
negative regulation of macromolecule metabolic process (GO:0010605),1/194,0.3616604646862284,0.3780298209379389,0,0,2.275302245250432,2.31409489747005,MMP8
negative regulation of intracellular signal transduction (GO:1902532),1/198,0.3675705199058439,0.38366470933674945,0,0,2.228652002256063,2.2305242656976114,MCL1
ncRNA processing (GO:0034470),1/201,0.37196790006266006,0.38770702136291363,0,0,2.194888888888889,2.1706303592171725,ADAR
regulation of angiogenesis (GO:0045765),1/203,0.3748828547359966,0.3901949713378894,0,0,2.172937293729373,2.131959366863807,ETS1
negative regulation of cellular process (GO:0048523),2/566,0.37545198147021946,0.39023771351124076,0,0,1.562701482914249,1.5308609633613448,RIPOR2;ETS1
regulation of protein kinase B signaling (GO:0051896),1/207,0.38067311265241294,0.39510875035131066,0,0,2.1303128371089537,2.0574864826074157,GAB2
negative regulation of multicellular organismal process (GO:0051241),1/214,0.39068006869646005,0.4049264667134418,0,0,2.059572248304643,1.9357225332832213,SRGN
cilium organization (GO:0044782),1/228,0.4102217340250427,0.4245852401183566,0,0,1.9311796377875674,1.720792005037741,FLNA
apoptotic process (GO:0006915),1/231,0.4143287609867219,0.4282362998170455,0,0,1.9057004830917874,1.679104142164637,ITGB2
cellular protein modification process (GO:0006464),3/1025,0.4216952918407664,0.4352413696512938,0,0,1.2924043143858372,1.1159553039074537,CTSG;DUSP6;JAK1
regulation of ERK1 and ERK2 cascade (GO:0070372),1/238,0.42380332490883554,0.4368070531487161,0,0,1.8487576183778716,1.587132140301504,DUSP6
membrane organization (GO:0061024),1/242,0.42914986750762174,0.4417016045795717,0,0,1.817704011065007,1.5376850350548765,ACTB
regulation of protein phosphorylation (GO:0001932),1/266,0.4602246936800637,0.47302649322610163,0,0,1.651069182389937,1.2812964617680371,ITGB2
negative regulation of signal transduction (GO:0009968),1/267,0.4614829085161668,0.4736609297131212,0,0,1.6447786131996658,1.2719241776072596,LTF
DNA metabolic process (GO:0006259),1/277,0.47390829714178995,0.4857395722438041,0,0,1.5843800322061192,1.1831222298457535,SAMHD1
plasma membrane bounded cell projection assembly (GO:0120031),1/278,0.47513529940328403,0.4863226956496218,0,0,1.5785800240673886,1.1747092828113983,FLNA
positive regulation of programmed cell death (GO:0043068),1/286,0.4848510522641142,0.4955808127568193,0,0,1.53364522417154,1.1102265493858519,DUSP6
positive regulation of apoptotic process (GO:0043065),1/310,0.5129546746127259,0.523582188589509,0,0,1.4128011506652283,0.9431405436903249,DUSP6
cilium assembly (GO:0060271),1/314,0.5174904465355594,0.5274833655031427,0,0,1.3944621938232162,0.9186217922015734,FLNA
transcription by RNA polymerase II (GO:0006366),1/320,0.5242167237841078,0.5336035246232171,0,0,1.367816091954023,0.8834041394718539,NR3C1
cellular protein localization (GO:0034613),1/329,0.5341344815916227,0.5429510067348131,0,0,1.3296747967479674,0.8338492151681215,FLNA
intracellular protein transport (GO:0006886),1/336,0.541708199261432,0.5498933506238987,0,0,1.3014262023217247,0.7978104420181629,SORL1
protein modification by small protein conjugation (GO:0032446),1/409,0.613850928714647,0.6222713804116929,0,0,1.0645969498910675,0.519526683574909,KLHL24
cellular protein metabolic process (GO:0044267),1/417,0.621046326273477,0.628703061802876,0,0,1.0436965811965813,0.4971644493468153,CTSG
organelle assembly (GO:0070925),1/425,0.6281105075679875,0.6349844939709204,0,0,1.0235849056603774,0.4760070652589166,FLNA
regulation of nucleic acid-templated transcription (GO:1903506),1/430,0.6324600294439127,0.6385081444795785,0,0,1.0113960113960114,0.463359203706559,NR3C1
"negative regulation of transcription, DNA-templated (GO:0045892)",2/948,0.6480080563046702,0.6533123514449539,0,0,0.9133192389006343,0.3962455155596343,FLNA;NR3C1
negative regulation of nucleic acid-templated transcription (GO:1903507),1/464,0.6607448634843653,0.6652458502928419,0,0,0.9354931605471563,0.38765667140538007,NR3C1
regulation of cellular macromolecule biosynthetic process (GO:2000112),1/468,0.6639291045576803,0.6675423241743207,0,0,0.9272900309302878,0.3797993631936268,NR3C1
negative regulation of cellular macromolecule biosynthetic process (GO:2000113),1/547,0.7211493024432954,0.7240887697086893,0,0,0.78990638990639,0.2582275761369665,NR3C1
regulation of transcription by RNA polymerase II (GO:0006357),4/2206,0.7619153343347201,0.7639829471823042,0,0,0.7677868604299122,0.20877647967833884,NAMPT;FOS;NR3C1;ETS1
"regulation of transcription, DNA-templated (GO:0006355)",4/2244,0.7739709811660549,0.7750197223329466,0,0,0.7531462585034013,0.1929718107760677,USP22;FOS;NR3C1;ETS1
negative regulation of transcription by RNA polymerase II (GO:0000122),1/684,0.7986199075491366,0.7986199075491366,0,0,0.6270050431104603,0.1409947222352381,NR3C1
